TSS:Hg 151036.1

Basic information about the TSS

---

TSS ID: hg_151036.1 Species: human Chr: chr15		Start: 77071099 End: 77071164 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000346495.6 ENST00000424443.7 ENST00000561277.5 ENST00000558394.5 ENST00000560514.1 uc002bck.4 uc010ump.3 uc059lyn.1 uc059lyq.1 uc059lyr.1 BC011206 BC000704 AK075336 AK075482 AK298157 AK095520 Distance: 0 GeneID: 10099 HGNC/MGI_ID: HGNC:17752 UniProt_ID: H0YMH8 O60637

Gene_name: tetraspanin 3 Gene_symbol: TSPAN3 Gene_synonyms: TM4-A TSPAN-3 Gene_source: HGNC:17752

TATA-Box annotation

---

Distance to TSS:	96
Nearest PromoterID:	NM_001168412
Entrez ID:	10099
Nearest Unigene:	Hs.744863
Nearest Refseq:	NM_005724
Nearest Ensembl:	ENSG00000140391
Gene Name:	tetraspanin 3
Gene Alias:	TM4-A
Gene Description:	tetraspanin 3
Gene Type:	protein-coding
CpG%:	0.13
GC%:	0.751244
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@TSPAN3 p2@TSPAN3 p3@TSPAN3 p4@TSPAN3 p5@TSPAN3 p6@TSPAN3 p7@TSPAN3
Sample		p1@TSPAN3	p2@TSPAN3	p3@TSPAN3	p4@TSPAN3	p5@TSPAN3	p6@TSPAN3	p7@TSPAN3
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	58.44	47.34	2.92	4.48	0.58	2.34	1.56
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	64.94	41.07	4.45	4.25	0.20	1.42	1.42
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	60.96	42.05	3.28	3.28	0.39	1.93	1.74
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	55.51	39.92	3.74	3.74	0.62	1.25	1.66
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	57.37	48.82	4.05	4.72	0.67	0.90	0.67
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	53.30	36.82	3.10	3.10	0.39	1.94	0.97
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	83.23	50.11	6.32	3.70	1.53	3.27	1.31
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	64.43	50.62	5.81	2.18	1.21	3.15	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	65.40	51.08	6.20	5.34	0.85	2.35	1.50
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	38.83	49.85	11.01	0.58	0.58	12.17	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	39.21	50.93	8.89	3.64	0.40	6.47	1.21
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	41.06	51.23	9.76	1.63	0.41	4.07	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	66.25	37.88	6.13	3.39	0.81	0.00	2.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	53.07	35.33	6.47	3.16	0.15	0.15	3.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	54.45	31.40	5.27	4.39	0.66	0.00	2.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	48.29	38.48	4.28	3.52	1.01	0.00	3.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	39.75	32.98	6.77	1.75	0.22	0.00	2.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	49.35	40.92	4.22	2.53	0.00	0.42	6.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	45.32	36.79	4.27	4.27	0.00	0.53	3.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	57.62	37.01	5.72	2.71	0.90	0.00	3.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	59.74	43.30	7.08	4.01	0.27	0.00	2.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	56.97	42.98	5.70	4.14	1.04	0.00	2.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	51.83	34.38	4.91	3.88	0.39	0.00	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	52.42	38.58	7.52	3.88	0.97	0.00	4.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	52.37	40.25	5.68	4.13	0.77	0.00	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	45.26	35.13	5.06	4.75	0.63	0.00	2.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	38.46	31.87	9.89	1.65	0.00	0.00	3.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	63.89	37.96	6.37	3.06	0.71	0.24	2.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	57.34	33.27	5.65	3.55	0.48	0.00	3.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	64.97	33.66	6.33	4.16	0.90	0.00	3.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	54.85	36.64	5.44	3.35	0.42	0.00	2.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	50.02	38.88	5.67	4.69	0.59	0.00	5.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	47.69	38.41	2.95	3.59	0.84	0.00	4.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	52.95	47.67	6.27	3.63	0.33	0.00	5.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	58.53	40.02	5.05	5.42	0.37	0.00	3.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	63.04	40.62	4.79	4.79	0.57	0.00	3.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	68.88	36.18	4.29	3.88	0.61	0.00	3.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	57.63	38.69	4.63	3.02	0.20	0.00	3.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	57.53	33.22	6.75	5.40	1.35	0.00	3.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	55.93	30.25	4.08	4.56	0.48	0.00	2.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	62.81	39.52	5.65	4.47	0.71	0.24	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	53.73	42.02	7.17	3.51	0.15	0.00	4.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	60.95	33.11	6.33	4.43	0.21	0.00	4.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	68.18	40.04	7.34	3.32	0.52	0.00	3.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	53.61	39.35	5.42	3.81	0.40	0.00	2.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	51.41	33.50	3.72	3.72	1.63	0.00	4.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	60.94	32.39	3.36	4.08	0.24	0.00	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	50.07	32.49	4.17	5.07	0.89	0.00	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	62.00	36.38	5.27	2.87	0.72	0.00	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	46.10	29.12	4.65	3.64	0.61	0.00	2.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	44.68	36.69	4.30	3.48	0.41	0.00	9.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	66.93	37.14	7.12	2.67	1.11	0.00	6.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	181.90	181.90	69.96	13.99	0.00	0.00	97.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	66.00	44.00	6.03	3.19	0.00	0.00	8.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	64.29	46.06	3.98	3.65	0.33	0.00	8.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	71.31	75.50	6.71	0.84	0.84	0.00	43.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	40.41	38.12	6.89	0.46	0.00	0.00	11.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	73.57	46.02	8.75	3.24	0.00	0.00	5.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	78.37	47.21	6.10	1.93	0.96	0.00	4.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	54.06	30.80	5.03	3.46	0.63	0.00	12.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	62.75	44.42	4.23	2.12	1.41	0.00	4.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	65.05	42.06	4.49	5.61	0.56	0.00	5.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	25.48	28.66	3.18	0.00	1.59	0.00	15.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	36.36	38.39	6.12	1.70	0.00	0.00	7.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	61.41	40.94	3.25	3.57	1.30	0.00	3.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	55.38	41.89	4.97	3.90	0.00	0.00	3.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	96.98	177.80	0.00	0.00	0.00	0.00	32.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	150.05	244.82	39.49	7.90	0.00	0.00	63.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	40.95	32.18	4.88	1.46	0.49	0.00	5.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	52.56	31.24	6.45	1.49	0.50	0.00	3.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	48.32	33.31	1.88	1.88	0.47	0.00	3.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	35.44	23.85	2.98	2.98	0.33	0.33	3.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	63.41	37.43	5.57	3.09	1.55	0.00	5.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	57.17	35.16	3.67	5.20	0.31	0.00	1.83
Adipocyte - breast, donor1	11376-118A8	108.81	53.53	6.65	6.18	1.43	0.16	1.11
Adipocyte - breast, donor2	11327-117E4	194.76	38.34	5.45	9.47	1.44	0.32	14.76
Adipocyte - omental, donor1	11473-119C6	127.48	59.03	7.25	7.89	2.42	0.64	1.78
Adipocyte - omental, donor2	11474-119C7	156.97	34.38	3.74	6.73	0.00	0.75	4.48
Adipocyte - omental, donor3	11475-119C8	114.88	29.47	7.03	7.03	2.01	0.00	4.35
Adipocyte - perirenal, donor1	11476-119C9	109.10	39.56	6.38	9.57	2.55	0.00	2.55
Adipocyte - subcutaneous, donor1	11259-116F8	84.66	25.29	2.20	4.40	1.10	0.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	51.03	19.42	5.87	2.71	0.00	0.90	1.81
Adipocyte - subcutaneous, donor3	11408-118E4	183.33	23.98	2.95	9.56	1.04	0.00	3.13
Adipocyte differentiation, day04, donor1	13019-139D4	100.92	36.77	3.52	8.61	3.13	0.78	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	53.28	17.24	0.77	2.06	1.03	0.00	1.29
Adipocyte differentiation, day04, donor3	13025-139E1	45.72	30.11	4.74	3.90	0.00	0.28	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	48.20	28.80	0.59	6.47	0.59	0.00	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	357.28	72.87	6.92	26.95	3.62	2.73	1.61
Adipocyte differentiation, day08, donor2	13023-139D8	114.90	22.59	2.26	3.55	0.32	0.00	1.61
Adipocyte differentiation, day08, donor3	13026-139E2	86.91	23.99	2.67	6.40	0.53	0.00	8.53
Adipocyte differentiation, day08, donor4	13029-139E5	122.42	38.95	3.90	7.23	1.67	1.67	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	331.47	73.20	9.57	31.19	2.50	10.40	2.91
Adipocyte differentiation, day12, donor2	13024-139D9	211.73	27.13	3.01	9.04	3.27	0.00	7.79
Adipocyte differentiation, day12, donor3	13027-139E3	198.31	39.60	5.24	13.09	0.98	1.96	4.25
Adipocyte differentiation, day12, donor4	13030-139E6	199.43	41.41	5.18	14.31	2.44	5.48	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	47.96	21.88	2.21	3.09	0.66	0.66	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	37.29	3.23	0.72	0.36	1.08	0.00	0.72
Alveolar Epithelial Cells, donor3	11671-122G6	11.98	7.19	0.00	1.20	2.40	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	37.78	19.97	2.16	1.26	1.26	0.00	0.72
Amniotic Epithelial Cells, donor2	11613-122A2	23.43	8.37	3.35	1.67	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	41.09	23.42	3.70	2.05	0.82	2.26	0.41
Anulus Pulposus Cell, donor1	11248-116E6	47.26	30.32	3.89	2.29	0.69	0.00	0.92
Anulus Pulposus Cell, donor2	11463-119B5	54.86	19.59	2.69	3.18	1.22	0.00	1.47
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	21.57	35.05	7.19	1.80	0.00	0.00	1.80
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	23.01	36.90	3.47	2.17	0.00	0.00	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	32.10	32.10	10.70	0.00	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	22.72	36.17	5.38	3.89	1.20	0.00	1.79
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	18.97	45.53	2.53	5.06	1.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	24.42	35.64	3.96	1.32	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	20.47	36.06	4.87	2.92	0.65	0.00	1.30
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	20.87	41.75	7.28	4.37	0.49	0.00	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	26.72	44.54	7.72	4.75	0.59	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	17.70	38.04	4.52	2.26	0.38	0.00	1.13
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	23.22	35.56	5.81	4.35	0.73	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	22.57	37.61	8.78	2.51	0.00	0.00	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	43.98	64.08	8.40	6.75	0.16	0.00	0.49
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	16.38	30.03	4.09	2.73	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	37.09	59.86	6.63	3.02	0.90	0.00	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	19.82	35.90	2.14	4.82	0.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	32.87	38.92	4.53	6.05	0.94	0.00	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	21.38	40.09	5.88	5.08	0.27	0.00	1.60
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	18.53	30.24	5.85	3.90	1.95	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	29.19	40.47	3.48	4.15	0.66	0.00	0.66
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	25.22	38.42	2.40	7.20	0.00	0.00	4.80
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	3.54	31.86	3.54	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	30.70	39.79	6.00	5.49	0.86	0.00	1.03
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	20.97	46.14	4.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	19.42	33.01	5.34	2.43	1.94	0.00	0.97
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	33.39	39.46	6.45	5.31	0.76	0.00	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	25.44	52.09	4.85	3.63	0.00	0.00	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	26.79	27.93	6.27	3.42	0.57	0.00	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	30.36	44.68	6.84	4.70	1.28	0.00	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	25.81	43.62	5.94	4.13	0.26	0.00	0.77
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	18.30	27.68	7.04	3.75	0.47	0.00	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	29.58	45.34	5.14	5.79	0.64	0.00	0.96
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	14.98	47.09	6.42	2.14	1.43	0.00	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	18.13	32.17	5.85	2.92	1.17	0.00	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	26.80	40.34	6.62	4.22	0.90	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	24.95	33.26	8.32	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	22.38	35.09	6.61	3.56	1.53	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	31.33	37.69	6.37	4.33	1.02	0.00	2.29
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	21.60	35.58	10.80	4.45	0.64	0.00	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	25.03	36.25	4.32	3.02	0.43	0.00	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	31.54	37.05	5.72	2.54	0.64	0.00	1.06
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	20.01	43.50	5.22	3.48	0.58	0.00	1.16
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	15.12	32.12	5.67	4.72	0.94	0.00	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	34.41	42.55	4.92	4.41	0.85	0.00	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	9.27	34.75	4.63	2.32	0.00	0.00	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	19.01	27.46	0.00	10.56	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	31.09	42.67	4.93	3.22	0.43	0.00	1.50
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	24.67	31.89	6.62	1.80	0.60	0.00	1.80
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	13.85	37.18	2.92	2.19	0.00	0.00	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	26.44	45.29	6.21	7.36	1.15	0.00	1.15
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	10.20	51.01	0.00	2.55	5.10	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	42.46	73.98	9.41	6.10	0.25	0.00	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	30.76	41.08	4.54	4.75	0.21	0.00	0.62
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	25.40	41.62	5.20	2.75	0.92	0.00	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	24.86	33.46	6.21	3.35	1.43	0.00	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	33.04	40.58	7.32	3.10	0.00	0.00	1.33
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	21.36	38.14	12.21	3.05	0.00	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	23.26	39.33	6.09	2.22	0.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	34.69	41.31	5.30	4.50	0.53	0.00	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	28.35	41.43	5.09	4.00	0.00	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	38.07	19.53	4.05	3.56	0.25	0.49	0.37
Astrocyte - cerebellum, donor2	11580-120F5	26.70	12.84	2.57	2.57	0.51	0.00	0.51
Astrocyte - cerebellum, donor3	11661-122F5	17.20	19.09	2.52	2.10	0.63	0.21	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	84.36	78.43	9.41	8.02	0.00	0.70	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	57.43	36.88	5.66	5.18	0.49	0.97	1.94
Astrocyte - cerebral cortex, donor3	11392-118C6	97.55	40.27	4.03	4.33	1.04	0.00	2.68
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	9.06	3.33	0.23	0.23	0.23	0.00	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	9.15	3.38	0.25	0.88	0.13	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	7.06	3.87	0.34	0.80	0.34	0.00	0.11
Basophils, donor1	12241-129G9	6.02	2.88	0.52	0.26	0.00	0.26	0.00
Basophils, donor2	12242-129H1	12.99	5.41	1.44	0.00	0.36	0.00	0.00
Basophils, donor3	12243-129H2	15.88	6.17	0.29	0.44	0.59	0.00	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	18.76	3.23	0.43	0.00	0.00	0.43	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	9.60	1.37	0.00	0.46	0.00	0.00	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	28.69	7.17	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	15.69	4.39	0.63	0.63	0.00	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	18.51	4.78	1.46	0.62	0.62	0.42	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	15.20	4.61	0.92	0.23	0.69	0.23	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	25.01	8.46	1.08	1.44	0.72	0.36	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	41.94	29.78	4.12	1.44	0.00	1.85	0.31
Burkitt's lymphoma cell line:RAJI	10476-106I8	58.23	24.45	2.10	2.33	0.23	0.00	1.16
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	53.40	81.86	12.15	4.16	0.32	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	31.03	144.79	20.68	20.68	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	11.83	6.76	0.56	0.00	0.00	0.00	0.56
CD14+ Monocytes, donor2	11305-117B9	19.49	4.27	0.93	0.56	0.93	0.00	0.00
CD14+ Monocytes, donor3	11381-118B4	19.10	5.05	0.00	0.44	0.22	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	38.21	27.17	1.98	1.98	0.57	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	51.55	14.03	1.90	1.52	1.52	0.00	1.52
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	38.79	20.71	2.30	1.97	1.31	0.33	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	9.25	3.90	0.72	0.43	0.43	0.58	0.58
CD14+ monocytes - mock treated, donor2	11873-125C1	15.39	5.13	0.30	0.30	0.00	0.00	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	6.87	6.16	0.24	0.47	0.24	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	19.59	3.85	0.17	0.33	0.17	0.50	0.67
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	27.33	4.42	0.00	0.28	0.00	1.66	0.83
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	27.02	6.69	0.25	1.74	0.00	1.74	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	8.03	2.94	0.39	0.39	0.78	1.17	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	7.83	3.74	0.36	0.00	0.71	1.07	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	9.14	6.96	0.44	0.22	0.22	1.96	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	11.47	3.51	0.00	0.47	0.00	0.23	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	15.84	4.75	1.06	1.58	0.00	0.53	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	14.42	4.44	0.00	1.11	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	18.15	6.54	1.19	1.04	0.45	1.19	0.59
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	18.56	5.79	0.00	1.00	0.60	2.00	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	22.28	11.03	0.42	0.21	0.62	1.67	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	13.50	4.80	0.00	0.69	0.92	0.23	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	19.00	6.56	0.45	0.00	0.23	0.90	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	12.66	4.80	0.00	0.00	0.00	0.87	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	8.34	2.96	0.54	0.27	0.27	0.00	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	8.90	5.06	0.35	0.70	0.17	0.70	0.35
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	5.47	2.95	0.42	0.00	0.00	0.84	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	11.02	3.86	0.18	0.18	0.18	0.55	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	13.74	3.17	0.00	0.00	0.35	0.35	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	9.21	2.63	0.00	0.00	0.00	0.44	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	10.11	2.09	0.87	0.17	0.35	1.22	0.52
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	13.75	2.23	0.00	0.37	0.37	3.35	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	17.46	5.17	0.22	0.22	0.43	1.72	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	10.65	4.50	0.41	0.41	0.82	0.00	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	10.43	3.25	0.00	0.00	0.46	0.70	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	8.82	4.87	0.23	0.46	0.00	0.23	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	13.08	5.67	1.09	1.53	0.65	0.00	0.87
CD14+CD16+ Monocytes, donor2	11801-124D1	13.86	10.16	0.46	0.69	0.23	0.23	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	20.80	7.80	0.65	1.08	0.87	0.00	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	11.37	9.34	1.40	0.93	0.78	0.00	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	10.30	7.16	0.87	0.17	0.17	0.00	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	12.26	6.69	0.00	0.00	0.22	0.22	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	16.84	7.40	1.02	0.77	1.28	0.00	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	17.35	7.03	0.66	0.44	1.10	0.00	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	26.53	8.21	0.00	0.63	0.42	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	162.58	58.94	6.10	2.03	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	166.78	49.49	7.46	6.10	1.36	0.00	4.75
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	164.66	79.74	7.25	5.18	0.00	0.00	3.11
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	141.79	101.28	6.93	13.86	0.53	3.20	2.13
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	147.95	115.79	14.47	8.58	0.54	5.90	3.22
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	172.68	74.41	5.62	1.40	0.00	0.00	1.40
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	156.09	61.96	6.27	6.27	0.00	0.00	5.49
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	181.92	73.82	6.59	7.91	2.64	1.32	0.00
CD19+ B Cells, donor1	11544-120B5	38.63	74.79	11.51	5.75	0.00	0.82	0.82
CD19+ B Cells, donor2	11624-122B4	52.96	55.13	9.43	4.35	0.00	2.18	0.00
CD19+ B Cells, donor3	11705-123B4	56.04	34.83	5.55	1.01	0.50	0.00	2.02
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	10.10	1.21	0.00	0.00	0.40	0.00	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	11.98	1.20	0.00	0.40	0.40	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	17.07	44.18	5.02	2.01	0.00	1.00	1.00
CD34+ Progenitors, donor2	11625-122B5	25.28	28.09	5.06	3.93	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	51.85	56.36	6.01	6.39	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	45.32	65.62	7.89	2.03	0.68	0.00	0.68
CD4+ T Cells, donor1	11225-116C1	12.85	11.43	0.00	0.36	0.00	0.00	0.36
CD4+ T Cells, donor2	11306-117C1	7.35	12.25	1.22	0.61	0.00	0.00	0.61
CD4+ T Cells, donor3	11382-118B5	5.18	5.49	0.61	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	1.28	2.55	0.51	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	1.57	2.70	0.22	0.22	0.22	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	0.86	1.44	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	7.59	12.33	1.42	1.90	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	9.13	13.34	2.11	0.70	0.70	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	9.89	9.89	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	2.75	6.07	1.16	0.72	0.29	0.14	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	3.39	3.05	0.34	0.17	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	3.22	2.10	0.00	0.16	0.00	0.16	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	2.69	2.69	1.34	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	1.75	3.49	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	1.32	1.32	0.44	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	2.53	3.37	0.84	0.42	0.00	0.00	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	4.36	5.19	0.21	0.83	0.42	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	3.34	5.68	0.33	0.33	0.00	0.00	1.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	7.34	26.65	1.90	1.63	0.54	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	12.33	18.22	6.43	0.00	0.00	0.00	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	7.17	25.11	1.79	0.00	5.38	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	4.64	6.30	1.30	0.19	0.00	0.19	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	5.63	6.50	0.65	0.22	0.65	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	5.88	3.57	0.21	0.42	0.21	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	3.03	6.57	0.51	0.51	0.51	0.51	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	3.47	5.20	0.87	0.43	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	6.97	7.41	0.87	0.00	0.00	0.00	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	10.39	4.95	0.49	1.48	0.49	0.00	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	17.54	6.46	0.92	1.85	0.92	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	11.17	8.37	1.40	0.00	0.00	0.00	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	14.68	14.12	2.49	0.55	0.55	0.28	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	14.48	9.08	0.74	1.23	0.49	0.25	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	18.48	3.08	3.08	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	15.76	8.59	0.00	0.72	0.36	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	13.85	8.31	1.38	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	7.20	12.77	0.65	0.98	0.65	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	6.01	7.51	1.50	0.75	0.00	0.38	0.38
CD8+ T Cells, donor3	11383-118B6	19.95	11.87	1.26	0.50	0.00	0.00	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	19.96	6.42	0.23	0.69	0.23	0.00	0.69
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	15.34	7.67	0.48	0.48	0.24	0.00	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	16.96	8.75	0.00	0.27	0.27	0.00	0.82
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	16.51	9.91	0.60	0.90	0.90	0.00	1.80
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	20.64	9.84	0.48	0.96	0.00	0.00	1.44
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	16.60	7.05	0.23	0.91	0.68	0.00	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	23.47	6.30	0.65	1.52	0.22	0.00	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	22.64	7.90	0.26	1.05	0.00	0.00	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	20.40	8.44	0.94	0.00	1.41	0.00	0.94
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	21.13	12.08	0.91	0.60	0.60	0.00	1.81
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	18.30	8.13	0.58	1.16	0.29	0.00	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	20.78	10.12	0.27	0.27	1.60	0.00	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	23.20	8.76	0.00	1.31	0.44	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	29.15	6.38	0.46	0.00	0.46	0.00	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	11.93	7.46	0.00	2.24	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	24.13	5.04	0.36	1.08	0.72	0.00	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	23.02	8.63	0.29	0.29	0.29	0.00	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	17.21	5.19	0.24	0.47	0.00	0.00	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	28.20	8.87	0.63	0.32	1.27	0.00	1.27
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	25.84	8.00	0.31	0.00	0.62	0.00	1.23
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	28.85	9.94	0.00	0.96	1.60	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	20.27	8.03	0.38	1.53	0.76	0.00	1.53
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	21.28	9.06	0.79	0.39	1.58	0.00	0.79
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	23.45	8.32	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	20.07	7.23	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	25.18	7.69	0.00	0.70	0.00	0.00	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	20.04	10.02	0.00	0.00	0.00	0.00	1.00
Cardiac Myocyte, donor1	11525-119I4	34.73	16.45	1.83	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	44.47	20.26	1.98	0.99	1.48	0.00	0.99
Cardiac Myocyte, donor3	11686-122I3	91.55	49.56	7.05	8.00	0.32	1.16	0.11
Chondrocyte - de diff, donor1	11261-116G1	84.24	26.35	2.77	3.81	1.04	0.00	0.69
Chondrocyte - de diff, donor2	11338-117F6	45.49	35.18	4.62	4.26	1.07	0.00	1.78
Chondrocyte - de diff, donor3	11410-118E6	82.60	40.51	4.55	6.14	1.14	0.23	0.91
Chondrocyte - re diff, donor2	11339-117F7	44.76	49.24	4.48	6.27	0.00	0.00	1.79
Chondrocyte - re diff, donor3	11411-118E7	36.80	26.69	3.24	4.85	1.62	0.40	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	64.61	72.30	12.74	5.39	1.49	2.64	1.03
Ciliary Epithelial Cells, donor2	11323-117D9	42.11	48.52	8.12	6.84	0.00	1.07	2.14
Ciliary Epithelial Cells, donor3	11399-118D4	59.29	59.56	7.79	7.96	1.06	0.44	0.97
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	79.87	57.22	7.70	5.96	2.11	0.18	0.73
Corneal Epithelial Cells, donor1	11526-119I5	14.49	1.98	0.66	0.88	0.66	0.66	0.00
Corneal Epithelial Cells, donor2	11606-120I4	11.38	5.69	2.28	0.00	1.14	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	20.71	2.05	1.02	0.00	1.53	0.00	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	50.68	9.25	1.16	0.83	2.48	0.33	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	58.98	5.68	0.63	1.89	3.78	1.26	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	34.51	6.90	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	48.06	11.34	0.65	0.97	1.84	0.00	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	59.45	142.81	13.32	6.83	0.68	0.00	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	110.34	89.44	12.40	5.88	0.65	0.00	1.96
Dendritic Cells - plasmacytoid, donor3	11385-118B8	64.36	124.37	13.07	9.68	0.97	0.00	0.97
Endothelial Cells - Aortic, donor0	11207-116A1	50.86	26.85	3.17	1.67	0.33	0.00	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	32.27	27.58	2.93	4.11	0.00	0.00	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	37.05	32.80	4.81	5.37	0.28	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	46.79	38.93	1.57	4.72	0.00	0.00	0.39
Endothelial Cells - Artery, donor1	11264-116G4	58.17	30.25	3.20	3.49	0.58	0.00	1.75
Endothelial Cells - Artery, donor2	11341-117F9	66.58	32.70	4.47	4.47	0.71	0.00	3.29
Endothelial Cells - Artery, donor3	11413-118E9	63.46	24.72	1.40	2.98	0.35	0.00	1.23
Endothelial Cells - Lymphatic, donor1	11236-116D3	52.97	56.96	4.21	5.54	0.22	0.22	0.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	90.06	62.07	4.87	7.61	1.22	0.30	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	62.02	62.30	5.36	8.18	0.56	0.00	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	41.90	15.45	2.97	3.57	0.59	0.00	0.59
Endothelial Cells - Microvascular, donor2	11342-117G1	32.28	26.03	3.64	1.56	0.00	0.00	1.56
Endothelial Cells - Microvascular, donor3	11414-118F1	38.28	19.99	3.26	2.69	0.00	0.00	0.71
Endothelial Cells - Thoracic, donor1	11266-116G6	62.02	30.01	5.60	4.80	1.20	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	48.22	34.07	5.24	4.19	0.00	0.00	2.62
Endothelial Cells - Umbilical vein, donor1	11243-116E1	56.16	54.54	5.72	4.60	0.87	0.12	0.50
Endothelial Cells - Umbilical vein, donor2	11324-117E1	33.02	31.94	2.82	3.69	1.09	0.22	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	50.07	17.83	2.08	2.32	0.98	0.37	0.61
Endothelial Cells - Vein, donor1	11267-116G7	40.95	42.09	4.55	3.41	2.28	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	34.23	27.24	3.49	2.79	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	58.09	36.27	5.18	4.24	0.94	0.00	1.73
Eosinophils, donor1	12244-129H3	15.25	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	14.85	0.00	0.00	1.65	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	0.00	7.13	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	13.19	1.95	0.49	0.24	0.24	0.00	0.49
Esophageal Epithelial Cells, donor2	11587-120G3	8.32	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	16.27	16.27	0.00	0.00	0.00	16.27
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	47.62	37.36	6.57	3.28	2.05	0.82	2.87
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	37.88	22.34	4.93	2.08	1.86	0.00	3.83
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	16.68	10.73	1.08	0.43	0.43	0.00	0.87
Fibroblast - Aortic Adventitial, donor1	11245-116E3	43.42	39.05	6.19	4.37	1.21	0.49	0.97
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	54.04	19.11	1.64	3.96	1.23	0.00	0.82
Fibroblast - Aortic Adventitial, donor2	11326-117E3	59.27	20.14	2.53	3.16	1.37	0.11	2.43
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	70.62	36.10	5.27	3.43	1.58	0.00	2.90
Fibroblast - Aortic Adventitial, donor3	11401-118D6	51.49	27.90	2.33	3.65	1.66	0.33	1.66
Fibroblast - Cardiac, donor1	11268-116G8	40.83	34.93	7.26	5.90	0.91	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	16.67	15.92	3.03	0.76	0.00	0.00	0.76
Fibroblast - Cardiac, donor3	11417-118F4	49.05	35.01	3.63	3.63	1.26	0.00	2.05
Fibroblast - Cardiac, donor4	11452-119A3	63.65	41.83	6.67	7.88	0.91	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	43.15	34.64	4.06	5.08	1.65	0.38	0.51
Fibroblast - Cardiac, donor6	11460-119B2	43.36	29.26	2.88	3.18	0.76	0.00	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	45.69	46.90	9.38	7.77	0.27	0.00	0.40
Fibroblast - Choroid Plexus, donor2	11572-120E6	29.34	58.67	5.18	5.61	0.43	0.00	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	62.99	19.04	7.32	1.46	0.00	0.00	2.93
Fibroblast - Conjunctival, donor1	11531-120A1	12.22	11.07	2.31	0.92	0.69	0.23	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	58.00	42.91	5.09	5.60	0.34	0.00	1.87
Fibroblast - Dermal, donor1	11269-116G9	44.37	10.33	2.82	1.88	0.70	0.00	1.41
Fibroblast - Dermal, donor2	11346-117G5	20.28	12.74	0.47	0.47	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	29.50	13.42	1.33	1.09	1.09	0.00	0.00
Fibroblast - Dermal, donor4	11450-119A1	30.07	12.21	2.37	1.36	1.58	0.11	0.68
Fibroblast - Dermal, donor5	11454-119A5	37.16	10.64	1.40	1.05	0.17	0.00	0.52
Fibroblast - Dermal, donor6	11458-119A9	51.49	8.45	1.62	1.14	0.97	0.00	1.14
Fibroblast - Gingival, donor1	11237-116D4	25.82	16.87	2.92	1.46	1.46	0.00	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	22.79	19.91	1.05	1.83	0.79	0.00	0.26
Fibroblast - Gingival, donor2	11318-117D4	36.90	18.05	0.92	2.24	0.66	0.00	1.19
Fibroblast - Gingival, donor3	11394-118C8	27.94	20.40	2.13	1.64	0.97	0.10	0.29
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	47.79	25.97	5.19	3.12	1.04	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	40.53	21.32	2.29	2.11	1.06	0.00	0.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	33.52	17.15	1.71	1.87	0.78	0.47	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	26.78	19.20	2.70	1.08	0.68	0.00	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	12.00	14.47	1.76	0.71	0.71	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	22.81	14.77	2.05	1.90	0.58	0.15	0.73
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	21.54	13.23	1.50	1.09	0.68	0.55	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	28.41	16.23	1.86	2.30	0.88	0.11	0.44
Fibroblast - Gingival, donor9 (control)	11927-125I1	49.74	31.99	4.55	3.08	0.73	0.15	0.88
Fibroblast - Lung, donor1	11270-116H1	21.75	8.16	1.36	4.08	0.00	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	50.73	25.37	0.00	1.49	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	65.84	24.90	2.53	4.22	1.90	0.00	2.11
Fibroblast - Lymphatic, donor1	11506-119G3	24.99	8.33	4.17	1.67	0.00	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	32.17	4.20	4.20	2.80	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	10.08	5.04	0.28	0.84	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	42.22	19.08	1.62	2.84	1.62	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	11.98	7.99	3.99	0.00	3.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	41.69	11.91	5.96	11.91	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	41.12	14.74	1.16	1.55	0.78	0.00	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	48.99	15.32	2.58	1.82	0.76	0.00	1.06
Fibroblast - Periodontal Ligament, donor3	11395-118C9	28.15	21.11	1.84	1.22	1.22	0.31	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	26.71	14.50	1.91	0.00	1.14	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	32.40	23.22	2.97	0.81	0.00	0.27	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	51.03	24.35	2.55	3.02	1.39	0.00	0.58
Fibroblast - Pulmonary Artery, donor1	11250-116E8	64.88	30.18	4.64	3.43	0.88	0.22	0.77
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	27.23	15.85	1.22	1.02	0.61	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	16.71	10.69	1.34	0.00	1.34	0.00	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	31.63	28.07	4.74	2.37	0.79	0.79	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	32.94	12.90	0.99	1.39	1.79	0.20	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	84.55	41.92	5.15	2.84	1.42	0.36	0.89
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	87.51	30.55	5.52	2.96	1.18	0.00	0.99
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	45.73	25.27	1.50	2.41	2.71	0.00	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	52.79	16.62	3.78	2.70	1.30	0.11	0.86
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	22.52	8.10	1.01	0.51	1.01	0.00	0.76
Fibroblast - skin normal, donor1	11553-120C5	60.87	29.37	4.27	2.30	1.15	0.00	0.82
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	73.59	20.25	2.41	1.20	2.21	0.00	0.40
Fibroblast - skin normal, donor2	11561-120D4	50.13	10.15	1.41	1.31	1.21	0.00	1.21
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	28.71	6.65	0.00	1.21	0.91	0.00	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	106.04	29.33	3.89	2.90	1.24	0.08	2.07
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	68.04	31.11	5.81	4.44	2.22	0.00	1.37
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	61.42	45.65	4.60	3.28	3.94	0.00	0.99
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	63.81	27.48	3.73	5.11	0.96	0.11	1.17
Fibroblast - skin walker warburg, donor1	11554-120C6	42.51	31.21	3.71	1.35	1.35	0.00	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	44.07	28.38	3.14	2.35	1.10	0.00	3.76
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	288.08	66.48	66.48	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	29.63	5.23	0.87	0.00	2.61	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	47.33	20.98	3.81	1.91	0.69	0.00	0.52
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	55.69	25.24	2.60	2.60	0.26	0.52	0.78
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	38.84	17.37	1.02	1.28	0.00	0.51	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	25.26	23.73	3.83	2.30	0.77	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	26.16	29.35	9.57	1.28	0.00	0.00	1.91
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	43.36	19.68	3.99	1.71	0.57	0.57	2.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	119.68	67.56	9.93	4.14	1.38	1.10	3.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	61.65	52.74	10.73	3.42	1.14	0.23	2.05
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	46.56	28.93	5.94	3.57	0.79	0.20	1.39
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	105.21	55.51	12.42	5.55	1.59	0.26	3.44
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	78.60	53.16	9.13	3.59	0.65	0.00	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	33.61	23.44	6.19	1.77	0.00	0.44	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	27.56	36.32	5.65	3.67	0.42	0.28	1.13
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	34.23	45.44	7.63	4.68	0.62	0.25	0.86
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	24.71	26.86	3.22	4.57	0.27	0.00	1.07
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	32.83	40.76	7.68	4.58	0.37	0.37	0.99
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	28.52	32.11	6.92	2.91	0.83	0.28	0.69
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	20.94	20.53	2.64	2.03	0.61	0.00	0.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	42.21	55.68	8.67	5.25	0.23	0.91	0.91
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	30.39	37.62	6.73	3.74	0.62	0.37	0.75
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	30.38	27.10	4.15	3.06	0.44	0.00	0.87
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	45.50	65.01	11.23	9.46	0.00	0.30	2.07
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	40.53	58.81	9.38	5.25	0.95	0.48	0.95
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	41.56	45.80	7.82	4.47	0.22	0.22	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	49.00	65.93	11.09	6.25	0.60	0.60	1.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	44.96	72.10	9.67	6.28	0.51	0.34	0.68
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	50.72	66.06	11.26	6.83	0.27	0.18	0.53
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	62.95	105.10	17.79	8.95	0.31	0.83	1.66
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	56.36	94.10	15.54	8.03	0.34	0.51	0.68
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	43.15	80.45	11.07	7.41	0.55	0.44	0.89
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	60.48	77.04	12.81	7.49	0.25	0.17	0.58
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	62.07	74.12	12.25	5.72	0.41	0.41	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	51.99	75.10	12.17	6.81	0.00	0.62	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	51.31	85.09	13.14	9.22	0.35	0.58	1.38
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	49.36	73.71	10.17	6.67	0.17	0.33	1.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	42.76	71.20	9.04	6.83	1.10	0.66	0.66
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	52.52	83.76	11.19	8.49	0.49	0.37	1.72
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	50.41	61.60	7.62	5.84	1.13	0.49	0.97
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	56.77	83.07	13.47	10.26	0.32	0.96	2.89
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	49.94	74.38	12.89	7.68	0.38	0.19	1.42
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	42.23	61.37	9.65	5.38	0.47	0.79	1.11
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	47.13	74.81	9.43	7.91	0.30	0.61	2.13
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	44.12	73.80	11.29	7.00	0.52	0.52	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	55.33	62.13	8.78	7.46	0.44	0.44	1.54
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	60.60	70.70	10.66	8.42	0.56	0.28	1.12
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	35.46	65.18	10.46	5.37	0.37	0.19	0.74
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	46.26	61.24	8.29	7.22	0.27	0.80	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	43.61	56.61	7.50	5.81	0.61	0.46	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	41.19	63.73	8.68	6.99	0.39	0.39	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	60.45	68.85	10.03	11.66	0.81	0.27	1.36
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	40.93	75.40	8.48	8.11	0.00	0.55	1.84
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	42.99	68.64	11.18	6.80	0.44	0.66	1.75
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	70.41	54.55	11.90	4.96	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	34.96	67.41	7.39	4.35	0.26	0.40	1.06
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	38.94	62.75	5.45	4.84	0.00	0.00	1.82
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	101.66	129.88	25.16	13.98	0.76	2.80	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	28.86	17.32	5.18	2.39	1.19	0.40	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	23.57	24.65	5.24	2.62	0.92	0.00	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	28.64	27.21	7.36	5.11	1.02	0.20	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	79.80	54.45	9.39	6.26	0.31	0.00	1.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	63.01	42.95	8.76	2.54	0.00	0.00	1.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	42.43	29.52	7.38	4.15	0.92	0.00	1.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	49.50	39.60	4.95	2.47	0.00	0.00	7.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	57.25	35.59	8.90	4.64	1.16	0.00	2.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	64.18	54.55	11.23	1.60	1.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	53.90	45.21	10.43	6.96	0.00	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	51.10	42.31	6.51	2.93	0.65	0.00	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	54.36	38.71	9.88	3.71	0.41	0.00	4.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	66.65	33.32	10.00	10.00	0.00	0.00	10.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	60.68	47.82	8.39	4.19	0.56	0.00	1.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	54.26	48.70	5.23	3.92	0.33	0.00	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	62.91	50.33	6.71	7.55	0.00	0.00	3.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	64.25	43.89	8.27	1.91	0.64	0.00	2.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	61.14	44.16	8.83	8.15	0.34	0.00	3.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	56.38	60.56	16.71	8.35	2.09	2.09	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	75.60	68.72	8.02	6.87	1.15	0.00	5.73
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	62.75	42.03	4.14	4.14	0.89	0.00	2.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	64.38	72.85	5.08	0.00	0.00	0.00	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	63.37	54.68	8.70	4.97	0.41	0.00	4.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	71.57	58.45	8.28	4.83	0.23	0.00	3.22
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	89.56	68.49	10.54	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	61.51	55.36	8.07	3.84	0.38	0.00	4.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	58.02	52.48	6.52	5.22	0.00	0.00	1.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	74.24	45.48	10.70	6.02	0.00	0.00	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	62.41	52.01	8.48	4.62	1.16	0.39	5.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	76.68	59.22	9.24	7.53	0.00	0.00	4.11
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	59.63	49.70	4.97	2.48	2.48	0.00	9.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	72.66	46.71	12.27	4.72	0.00	0.00	1.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	71.82	50.69	10.86	6.64	0.60	0.00	3.62
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	76.30	57.99	9.66	5.09	0.51	0.00	3.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	65.41	53.05	12.36	6.38	1.20	0.00	5.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	86.83	55.26	11.84	6.41	0.00	0.00	4.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	90.89	48.40	9.44	7.08	0.00	0.00	9.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	82.27	57.18	9.34	7.58	0.58	0.00	4.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	75.05	50.47	7.02	7.46	0.00	0.00	1.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	82.23	38.99	9.32	5.09	0.00	0.00	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	53.13	63.27	6.57	4.18	0.60	0.00	5.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	54.35	48.52	10.68	8.73	0.00	0.00	4.37
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	27.39	21.68	2.28	4.57	0.00	0.00	2.28
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	21.62	26.61	1.66	1.66	0.00	0.00	1.25
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	19.12	16.87	2.25	0.00	1.12	0.00	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	45.67	28.23	2.54	4.76	1.90	0.00	0.95
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	38.43	29.24	1.67	2.51	0.84	0.00	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	58.83	15.90	1.74	1.74	1.28	0.00	2.44
Hep-2 cells mock treated, biol_rep2	11899-125E9	51.15	18.23	2.19	1.69	1.01	0.00	2.53
Hep-2 cells mock treated, biol_rep3	11900-125F1	61.65	20.93	2.28	2.50	2.05	0.00	2.96
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	54.22	17.71	2.40	1.53	0.98	0.00	2.95
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	62.75	21.71	1.29	2.79	0.64	0.00	1.93
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	53.82	18.30	1.72	2.15	0.86	0.00	3.01
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	53.80	17.06	1.49	1.74	1.49	0.00	2.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	50.44	16.98	3.26	1.03	0.69	0.00	1.72
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	48.38	22.75	2.56	1.92	0.64	0.00	2.56
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	34.70	17.35	3.36	3.92	0.56	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	13.85	14.28	3.03	0.87	0.00	0.43	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	47.59	47.59	7.93	7.93	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	47.97	28.22	4.59	4.23	0.71	0.71	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	25.43	13.08	1.45	1.45	0.73	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	45.11	29.20	2.97	3.32	0.70	0.00	0.52
Hepatocyte, donor1	11523-119I2	4.84	1.21	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	35.55	21.55	2.15	0.00	1.08	0.00	1.08
Hepatocyte, donor3	11684-122I1	30.06	3.07	0.61	0.61	1.84	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	41.12	17.62	2.61	0.00	0.65	0.00	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	55.76	33.91	4.19	1.92	0.70	0.00	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	73.68	53.92	8.64	6.86	0.96	0.41	0.69
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	12.74	3.18	0.00	3.18	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	9.69	8.31	0.00	0.00	1.38	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	5.01	12.51	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	11.87	11.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	10.25	5.13	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	13.71	4.57	4.57	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	17.87	8.12	1.62	1.62	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	10.00	1.67	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	14.52	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	18.53	2.65	1.32	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	8.87	3.33	1.11	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	5.24	0.00	5.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	10.08	6.30	0.63	0.63	0.00	0.00	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	10.83	3.09	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	6.46	3.23	0.65	1.94	1.94	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	11.27	3.22	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	11.95	11.95	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	4.89	5.70	0.00	0.81	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	7.56	2.94	0.42	0.00	0.84	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	14.37	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	7.23	5.63	0.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	8.31	6.46	0.00	0.00	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	5.66	1.89	0.00	0.94	0.00	0.00	0.94
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	9.07	1.81	0.91	0.91	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	29.48	0.00	0.00	14.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	6.46	10.76	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	11.43	7.62	1.27	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	9.57	5.10	0.64	0.64	0.64	0.64	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	7.29	3.65	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	7.85	3.57	0.71	0.00	0.00	0.00	1.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	3.32	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	8.95	3.09	0.31	0.31	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	12.29	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	9.43	3.14	3.14	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	15.99	6.26	0.70	0.00	0.00	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	15.49	0.00	0.00	2.21	2.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	9.73	3.24	3.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	6.98	6.98	3.49	2.62	0.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	6.75	11.25	2.25	0.00	4.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	10.45	10.45	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	8.53	9.60	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	5.54	1.39	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	11.40	2.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	11.05	6.44	1.84	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	12.10	6.05	0.00	3.03	3.03	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	6.21	6.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	10.57	13.75	0.00	0.00	1.06	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	19.42	11.02	1.14	1.80	0.33	0.73	0.41
Keratinocyte - epidermal, donor2	11349-117G8	8.20	3.51	2.93	0.59	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	30.10	7.00	1.14	0.66	0.85	0.57	0.47
Keratinocyte - oral, donor1	11251-116E9	44.95	14.76	2.84	2.72	1.02	0.57	0.45
Keratocytes, donor1	11527-119I6	19.60	12.03	0.69	0.34	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	22.26	3.52	1.17	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	24.50	25.89	0.59	0.99	0.79	0.20	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	98.91	6.59	4.40	0.00	4.40	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	36.68	26.97	2.16	1.08	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	115.68	73.70	11.76	8.65	0.46	0.12	0.58
Lens Epithelial Cells, donor3	11690-122I7	56.91	59.03	7.97	8.07	1.01	0.91	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	76.84	30.71	3.08	3.91	0.36	0.00	1.90
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	27.63	31.26	2.79	2.51	0.00	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	46.59	28.49	3.15	3.15	0.47	0.16	1.26
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	45.71	16.67	2.69	1.08	0.54	0.00	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	32.78	25.53	2.21	3.78	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	36.01	20.05	2.37	2.05	0.54	0.22	1.62
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	43.09	17.65	1.64	1.23	0.82	0.00	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	27.81	29.33	2.02	2.53	0.00	0.00	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	33.64	20.13	2.39	2.53	0.70	0.14	1.13
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	48.65	15.82	4.35	1.58	0.79	0.00	2.37
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	44.98	30.63	3.68	3.49	0.78	0.00	0.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	28.88	15.00	2.04	1.11	0.93	0.00	0.56
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	51.22	16.38	3.14	1.74	0.35	0.00	2.09
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	36.49	31.49	4.29	3.58	0.95	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	31.59	21.43	3.02	2.20	0.82	0.14	1.51
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	60.05	22.48	1.54	2.16	0.00	0.00	1.85
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	23.38	15.59	2.18	3.12	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	29.64	21.78	3.48	1.65	0.73	0.18	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	43.77	21.39	3.95	2.30	0.00	0.00	1.32
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	22.55	20.79	3.81	2.05	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	25.89	16.68	0.75	2.99	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	47.04	19.40	1.94	1.94	0.48	0.00	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	37.97	31.24	3.50	3.77	1.62	0.27	0.81
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	32.09	19.07	2.72	3.33	0.30	0.00	1.51
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	36.81	18.14	2.59	4.15	1.04	0.00	1.56
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	41.04	34.97	4.82	4.61	1.26	0.63	1.47
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	37.59	24.96	1.80	1.95	0.75	0.15	1.50
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	57.09	22.01	1.38	4.82	0.69	0.00	2.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	36.31	33.30	3.57	3.57	0.19	0.00	0.56
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	35.31	22.27	2.33	2.23	0.85	0.00	1.17
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	50.88	25.20	2.91	1.94	0.00	0.00	1.45
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	33.74	32.42	3.31	3.64	0.66	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	32.58	19.45	2.48	3.22	0.62	0.25	0.62
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	56.27	28.51	3.70	5.18	0.00	0.00	3.70
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	34.34	34.84	4.69	1.73	0.25	0.00	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	34.92	20.49	2.06	3.16	0.55	0.00	0.55
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	55.97	21.87	2.89	2.25	0.64	0.00	1.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	29.82	39.26	4.26	3.65	0.30	0.00	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	44.51	29.53	4.06	2.24	0.84	0.00	0.98
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	56.18	17.78	1.07	2.13	0.00	0.00	1.78
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	32.48	31.51	2.91	2.91	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	27.54	19.30	2.33	1.71	0.00	0.16	0.93
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	59.80	19.34	3.94	3.22	0.00	0.00	3.22
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	40.83	30.71	4.90	2.94	0.33	0.00	1.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	25.90	16.24	1.18	0.94	0.24	0.00	0.94
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	79.08	28.09	3.34	3.22	0.62	0.00	1.36
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	34.83	29.45	4.10	5.63	0.77	0.00	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	32.82	19.99	3.28	3.28	0.00	0.30	1.19
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	27.19	6.80	0.00	0.00	2.27	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	23.78	2.30	0.77	0.00	1.53	0.00	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	19.30	0.74	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	16.50	3.81	0.00	0.00	0.00	0.00	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	21.80	6.33	0.70	0.00	1.41	0.00	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	22.42	5.60	0.93	0.93	0.93	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	8.24	1.55	0.52	0.00	0.52	0.00	4.12
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	15.46	2.38	0.00	0.00	0.00	0.00	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	24.66	3.62	0.45	0.68	0.45	0.00	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	17.45	3.20	0.29	0.58	0.58	0.00	3.49
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	19.36	4.95	0.45	0.90	0.00	0.00	1.35
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	23.03	3.25	0.41	0.00	0.54	0.00	1.08
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	16.95	5.14	0.00	0.51	0.00	0.00	1.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	23.29	2.82	0.00	0.35	0.71	0.00	1.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	17.99	2.00	0.00	0.00	0.00	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	13.75	6.11	0.00	0.00	0.51	0.00	2.55
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	22.68	3.47	1.07	0.27	0.53	0.00	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	18.33	3.40	0.57	0.57	0.19	0.00	1.51
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	21.47	3.68	0.00	0.00	0.61	0.00	1.84
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	28.54	1.63	0.82	0.00	0.82	0.82	4.08
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	23.95	3.96	0.83	0.21	0.42	0.00	1.46
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	22.98	2.24	0.84	0.28	0.56	0.00	3.36
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	34.00	4.12	0.00	0.00	0.00	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	31.64	5.23	0.58	0.29	0.58	0.00	1.74
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	18.23	3.59	0.30	0.60	0.90	0.00	1.79
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	30.43	2.21	0.55	0.55	1.11	0.55	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	21.21	3.89	1.06	0.00	1.77	0.00	2.47
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	22.50	3.32	0.00	0.37	0.37	0.00	3.69
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	20.72	1.15	0.00	0.00	0.00	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	23.41	2.30	0.77	0.38	0.77	0.00	3.45
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	22.08	2.83	0.00	0.00	1.70	0.00	3.96
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	18.87	2.46	0.82	1.64	0.82	0.00	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	21.69	2.26	0.90	0.45	0.90	0.00	2.26
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	15.08	6.46	0.72	0.00	0.72	0.00	2.87
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	26.89	2.99	0.75	1.49	0.00	0.00	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	21.55	3.72	0.00	0.00	0.00	0.00	1.11
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	18.95	2.15	0.00	0.00	0.43	0.00	2.58
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	20.55	2.57	1.71	0.00	1.71	0.00	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	22.99	3.66	0.33	1.00	0.00	0.00	2.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	18.10	3.62	0.60	0.60	0.60	0.00	2.41
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	12.80	4.98	0.00	0.71	0.00	0.00	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	21.31	2.06	0.00	0.00	0.34	0.00	2.06
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	13.42	2.68	0.54	0.54	0.54	0.54	2.15
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	24.24	4.04	0.00	0.67	0.67	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	25.19	4.44	0.37	0.37	0.37	0.00	1.85
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	29.07	5.81	1.16	0.00	1.16	0.00	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	32.79	1.06	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	22.41	2.40	1.20	0.00	0.40	0.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	21.81	1.45	0.73	0.00	0.73	0.00	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	26.83	6.13	3.07	0.00	1.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	17.26	2.96	0.99	0.00	1.48	0.00	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	29.17	0.94	0.00	0.94	0.00	0.00	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	25.14	3.02	0.00	1.01	1.51	0.00	1.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	17.57	2.25	0.00	0.45	0.45	0.00	3.15
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	10.33	5.16	0.00	1.72	0.00	0.00	5.16
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	20.93	3.56	0.89	0.89	0.45	0.00	1.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	24.24	3.13	1.17	1.56	0.00	0.00	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	15.83	1.98	0.66	0.00	0.00	0.00	3.30
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	28.02	1.04	1.04	0.52	1.56	0.00	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	22.75	4.81	0.88	0.00	0.44	0.00	3.94
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	22.92	3.35	0.56	0.56	0.00	0.00	2.24
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	22.97	3.09	1.32	1.32	0.88	0.00	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	23.14	1.93	0.39	1.16	0.77	0.00	1.16
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	20.25	3.54	0.51	0.00	0.00	0.00	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	27.40	3.36	0.48	0.00	1.92	0.00	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	22.26	5.17	0.00	0.00	0.40	0.00	1.99
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	17.01	3.65	1.82	0.00	0.61	0.00	1.82
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	15.22	3.46	0.00	0.69	0.69	0.00	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	21.28	3.80	0.00	0.38	0.76	0.00	1.90
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	14.98	4.65	1.03	0.00	0.00	0.00	5.16
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	11.49	0.60	1.21	0.60	0.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	22.82	2.85	0.32	0.63	0.95	0.00	0.95
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	23.46	2.13	0.53	0.00	0.00	0.53	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	14.37	2.30	0.00	0.57	1.15	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	24.17	3.09	0.51	0.00	1.03	0.00	3.09
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	21.22	1.41	0.71	0.00	1.41	0.00	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	23.27	1.13	1.70	0.57	1.13	0.00	2.27
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	23.71	2.50	0.42	0.00	0.42	0.00	4.99
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	21.14	4.70	0.78	0.00	0.00	0.78	2.35
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	19.21	4.18	0.42	0.84	0.84	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	24.63	6.04	1.39	0.46	1.39	0.00	3.72
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	25.42	2.68	0.00	0.00	0.67	0.00	4.68
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	17.64	1.60	0.53	0.00	1.60	0.00	3.74
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	21.82	3.23	0.40	0.81	0.81	0.00	2.42
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	28.45	1.84	0.00	0.00	0.00	0.00	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	19.56	3.56	0.89	0.89	0.00	0.00	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	25.07	5.13	1.14	0.00	2.28	0.00	1.71
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	20.71	1.53	0.77	0.77	0.77	0.00	3.07
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	17.51	3.28	0.00	1.64	0.55	0.00	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	25.84	4.01	1.34	0.45	1.34	0.00	1.34
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	28.60	4.94	0.26	0.00	0.78	0.00	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	21.22	3.32	0.00	0.66	1.33	0.00	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	27.02	4.16	2.08	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	31.45	15.73	1.82	1.14	1.82	0.00	0.68
Macrophage - monocyte derived, donor2	11313-117C8	101.30	12.66	0.92	2.75	3.67	1.10	0.55
Macrophage - monocyte derived, donor3	11389-118C3	55.45	14.94	1.44	1.05	3.28	1.97	0.52
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	45.14	32.92	5.84	4.78	1.06	0.00	0.53
Mallassez-derived cells, donor2	11929-125I3	57.04	37.87	4.60	3.49	0.48	0.95	0.95
Mallassez-derived cells, donor3	11930-125I4	36.83	22.10	2.50	2.50	0.28	0.00	0.56
Mammary Epithelial Cell, donor1	11273-116H4	18.53	6.08	1.00	0.30	0.80	0.10	0.20
Mammary Epithelial Cell, donor2	11350-117G9	24.32	8.98	2.61	1.74	1.16	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	15.22	4.49	0.75	0.50	0.25	0.00	0.25
Mast cell - stimulated, donor1	11487-119E2	8.81	22.37	3.39	0.68	0.68	0.00	0.00
Mast cell, donor1	11563-120D6	18.06	21.63	2.92	2.49	0.65	0.00	0.11
Mast cell, donor2	11565-120D8	16.34	8.32	1.19	0.59	1.49	0.00	0.00
Mast cell, donor3	11566-120D9	19.81	6.75	1.35	1.13	0.90	0.00	0.00
Mast cell, donor4	11567-120E1	15.78	7.62	1.42	0.71	0.89	0.00	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	24.06	19.18	2.55	1.44	0.55	0.11	0.44
Mast cell, expanded and stimulated, donor8	11942-126A7	21.01	7.59	0.58	1.75	0.58	0.00	0.58
Mast cell, expanded, donor5	11939-126A4	13.54	16.29	1.95	1.84	0.57	0.00	0.23
Mast cell, expanded, donor8	11941-126A6	18.24	12.55	1.00	0.67	1.00	0.00	0.50
Melanocyte - dark, donor1	11502-119F8	53.03	53.83	6.47	6.07	0.80	0.00	0.40
Melanocyte - dark, donor2	11582-120F7	45.34	23.88	4.15	2.77	0.35	0.00	2.77
Melanocyte - dark, donor3	11663-122F7	92.07	32.82	4.20	3.91	0.36	0.72	0.51
Melanocyte - light, donor1	11274-116H5	33.38	11.52	2.35	2.12	0.71	0.00	0.00
Melanocyte - light, donor2	11351-117H1	28.66	21.84	1.36	2.05	0.00	0.00	0.68
Melanocyte - light, donor3	11423-118G1	33.82	15.61	2.60	3.47	0.00	0.00	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	50.92	32.07	4.06	3.12	0.52	0.83	1.87
Melanocyte, donor2 (MC+2)	12739-135I3	57.55	24.20	3.50	4.30	0.27	1.34	1.34
Melanocyte, donor3 (MC+3)	12837-137B2	61.07	40.45	7.50	4.02	0.54	0.27	2.68
Meningeal Cells, donor1	11493-119E8	43.05	17.24	3.47	2.48	0.50	0.00	0.12
Meningeal Cells, donor2	11573-120E7	71.30	29.93	4.84	3.96	0.88	0.00	0.44
Meningeal Cells, donor3	11654-122E7	46.86	34.64	4.65	3.50	0.41	0.00	0.98
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	50.47	27.95	3.99	2.57	1.14	1.71	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	37.03	38.34	6.04	3.42	0.91	0.30	0.30
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	11.83	5.26	0.00	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	7.85	0.00	0.00	1.31	2.62	0.00	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	30.14	14.35	3.59	4.31	1.44	1.44	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	25.20	36.42	4.02	3.60	0.21	0.21	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	22.12	19.10	3.02	3.52	0.00	0.00	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	22.85	14.94	1.54	1.10	0.88	0.66	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	19.73	8.77	0.73	0.73	0.73	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	16.16	7.16	0.20	2.25	1.23	0.20	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	47.65	31.72	7.20	6.09	0.83	0.97	0.42
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	26.76	18.21	1.49	1.86	0.74	0.37	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	52.23	52.76	9.08	4.47	0.92	0.26	0.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	32.05	10.98	1.78	0.89	0.00	0.00	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	21.02	16.35	2.34	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	21.77	5.12	1.92	2.56	0.64	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	47.50	19.85	4.25	2.84	0.71	0.00	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	54.41	53.48	6.88	6.25	1.25	0.31	0.94
Mesenchymal stem cells - umbilical, donor0	11214-116A8	34.83	13.79	2.90	2.90	2.18	0.00	1.45
Mesothelial Cells, donor1	11247-116E5	274.19	82.73	6.89	14.32	3.18	3.71	3.18
Mesothelial Cells, donor2	12156-128G5	186.17	45.04	3.50	6.51	3.50	0.50	6.01
Mesothelial Cells, donor3	11402-118D7	281.90	67.42	8.02	16.40	2.75	1.59	3.40
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	33.76	4.05	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	47.78	15.52	0.99	2.22	2.46	0.00	0.74
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	66.55	15.61	0.88	3.24	1.18	0.00	0.88
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	55.31	20.74	0.00	3.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	32.23	13.64	2.79	2.79	0.31	0.00	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	59.33	9.13	1.24	2.49	0.21	0.41	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	41.69	6.95	2.32	2.32	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	46.80	17.77	0.50	3.50	2.75	0.75	0.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	67.96	11.17	1.40	0.93	1.86	0.47	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	77.86	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	43.89	13.41	1.22	2.03	2.85	0.61	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	60.19	14.65	1.19	1.98	2.38	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	0.00	8.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	34.51	11.50	0.88	1.77	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	74.47	14.44	0.76	2.66	2.66	0.76	1.14
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	34.21	1.32	0.00	1.32	1.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	37.56	13.79	1.27	1.91	0.85	0.00	0.64
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	35.91	4.60	0.92	0.92	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	33.98	13.11	2.09	0.60	1.19	0.00	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	38.56	1.68	0.00	1.68	0.00	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	101.85	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	31.61	13.05	0.50	1.00	1.51	0.50	0.75
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	60.61	10.93	0.71	2.14	1.66	0.48	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	23.77	5.53	0.55	1.66	0.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	28.09	10.59	2.30	1.61	1.84	0.69	0.92
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	49.01	12.83	0.84	1.47	0.21	0.42	0.63
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	27.92	8.76	0.61	1.02	0.61	0.00	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	26.82	10.94	1.72	1.50	0.64	0.00	0.86
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	48.01	8.22	0.44	1.33	1.56	0.44	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	61.91	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	23.43	6.13	0.88	1.31	0.88	0.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	36.50	4.56	0.51	1.52	0.51	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	24.85	4.97	3.31	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	23.65	8.70	0.27	0.82	0.54	0.00	0.54
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	47.94	8.82	0.88	2.06	1.47	0.29	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	18.54	3.27	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	28.35	13.46	0.48	0.00	0.48	0.00	1.92
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	53.63	12.41	1.60	1.60	1.60	0.40	1.20
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	21.94	9.60	0.00	0.00	0.00	0.00	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	29.53	8.51	1.50	0.50	1.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	161.68	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	28.54	2.04	0.00	0.00	2.04	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	26.71	12.70	0.44	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	38.63	4.41	0.00	1.10	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	37.78	3.84	0.64	1.28	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	35.20	15.87	1.98	0.99	0.50	0.50	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	46.63	8.35	0.00	2.78	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	24.31	8.84	0.00	0.00	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	42.05	19.15	1.37	2.39	0.68	0.34	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	65.20	6.56	0.88	3.94	0.88	2.19	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	25.21	8.17	0.71	0.36	0.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	46.57	27.49	2.24	2.24	1.40	1.68	1.40
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	78.97	14.13	0.83	3.33	0.83	1.25	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	36.71	7.58	2.33	0.58	1.17	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	43.44	16.89	2.11	3.92	0.90	3.62	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	82.23	15.03	2.92	2.09	2.09	2.50	1.25
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	21.66	7.22	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	34.17	20.32	3.69	0.92	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	106.99	18.21	2.85	5.69	3.41	1.14	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	39.80	16.03	0.69	2.21	0.28	0.00	0.83
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	49.24	27.99	2.33	2.33	2.07	1.04	1.81
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	96.09	14.16	1.29	4.29	2.14	5.58	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	37.48	13.97	0.64	1.91	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	40.57	21.88	2.94	3.20	0.53	1.07	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	133.20	30.83	3.89	6.59	2.69	2.39	1.50
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	33.48	15.54	1.84	2.54	0.85	0.14	0.42
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	51.60	37.27	3.82	4.78	2.23	1.27	1.91
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	137.99	22.11	2.87	6.41	1.77	3.10	1.33
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	59.16	15.55	0.76	1.14	0.76	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	47.45	30.40	2.56	4.83	0.57	1.70	1.14
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	143.80	25.32	2.95	6.15	3.20	4.92	2.95
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	43.01	15.64	1.96	0.65	0.65	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	50.87	29.99	2.94	3.53	1.47	0.29	1.18
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	151.08	26.53	3.75	7.21	1.73	3.17	4.32
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	60.59	22.67	2.89	2.47	0.41	0.00	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	54.49	39.61	2.08	3.87	1.49	1.19	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	33.90	26.37	3.77	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	16.04	16.04	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	33.84	22.01	0.99	0.33	1.31	0.33	0.99
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	17.88	12.62	1.05	1.05	2.10	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	29.65	13.44	1.38	1.19	0.59	0.00	0.99
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	41.91	9.31	0.00	0.93	0.93	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	29.67	14.65	0.00	1.50	1.50	0.00	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	34.89	10.92	0.80	0.80	1.07	0.53	1.33
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	27.48	12.67	0.90	0.79	0.45	0.00	0.34
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	14.00	11.79	0.74	0.00	0.00	0.00	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	27.12	16.12	1.47	1.47	0.37	0.00	1.10
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	28.00	14.00	0.00	0.00	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	23.52	14.96	2.67	0.53	0.53	0.00	2.67
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	11.59	7.73	0.00	7.73	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	29.29	15.15	2.02	0.00	0.00	0.00	2.02
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	25.72	13.49	1.26	0.42	0.84	0.00	1.26
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	27.24	13.62	0.00	0.00	2.72	0.00	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	14.62	12.08	3.81	2.54	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	45.35	16.20	2.43	2.43	1.62	0.00	1.62
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	16.61	6.04	0.00	0.00	0.00	0.00	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	34.26	17.13	5.71	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	32.62	13.05	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	57.03	0.00	4.75	4.75	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	0.00	0.00	0.00	12.55	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	38.13	47.40	4.31	6.03	1.08	0.00	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	32.92	37.63	4.70	2.09	0.00	0.00	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	14.68	26.03	0.67	2.67	0.00	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	20.87	12.94	1.25	0.42	1.25	0.00	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	26.43	18.06	2.28	1.52	0.19	0.00	1.14
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	19.15	30.32	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	11.56	19.04	2.04	2.72	0.68	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	33.08	42.27	5.51	3.68	0.00	0.00	5.51
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	17.58	30.97	2.51	1.26	0.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	29.29	19.52	2.32	1.39	1.16	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	19.46	27.02	2.97	1.89	0.27	0.00	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	26.07	38.47	2.31	2.94	0.21	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	55.67	178.16	11.13	0.00	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	22.83	20.85	4.96	1.99	0.00	0.00	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	23.28	32.21	5.41	2.98	0.54	0.00	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	23.12	29.24	3.40	2.27	0.23	0.00	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	34.29	34.29	3.92	2.61	0.16	0.00	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	27.70	53.22	4.74	4.92	0.00	0.00	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	16.97	45.62	4.77	2.12	0.53	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	26.41	37.82	5.40	2.40	0.00	0.00	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	17.72	27.90	5.25	2.30	0.00	0.00	1.64
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	32.36	27.65	2.76	4.23	0.49	0.00	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	27.87	42.86	4.76	3.70	0.71	0.00	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	36.57	70.32	7.74	4.92	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	28.04	38.62	6.44	0.92	0.00	0.00	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	40.17	62.34	5.78	5.46	0.32	0.00	0.96
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	35.87	36.21	3.10	1.72	1.03	0.00	6.90
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	65.74	149.18	12.64	10.11	0.00	0.00	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	31.41	43.22	5.12	3.12	0.67	0.00	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	42.34	51.23	5.08	4.66	0.85	0.00	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	32.04	17.80	2.85	2.14	0.24	0.00	0.95
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	50.65	63.10	8.58	6.01	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	153.47	243.75	0.00	18.06	0.00	0.00	36.11
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	42.65	41.99	4.67	6.33	1.00	0.00	1.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	31.11	33.36	4.96	4.51	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	36.11	53.96	3.57	5.16	0.00	0.00	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	32.50	37.15	0.00	4.64	0.93	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	48.81	41.62	3.41	1.51	1.14	0.00	1.51
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	44.32	38.78	3.91	4.89	0.65	0.00	1.96
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	36.61	24.84	2.61	1.31	0.87	0.00	0.87
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	29.85	29.40	3.62	2.26	0.90	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	28.22	38.80	5.29	4.41	0.00	0.00	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	47.20	50.53	1.99	5.98	0.66	0.00	1.33
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	39.19	64.49	7.94	8.93	0.50	0.00	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	56.28	29.09	2.68	4.21	1.15	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	111.30	63.51	7.26	7.26	0.00	0.00	3.02
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	33.37	46.19	5.75	4.64	1.33	0.00	1.11
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	42.01	56.92	0.68	3.39	0.68	0.00	1.36
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	86.86	163.50	20.44	15.33	0.00	0.00	20.44
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	56.70	77.43	7.32	9.75	1.22	0.00	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	55.08	30.21	4.09	4.72	1.26	0.00	0.94
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	51.75	32.08	3.33	2.72	0.30	0.00	1.51
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	45.89	64.87	7.12	4.75	0.00	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	29.47	31.74	5.67	3.40	0.00	0.00	5.67
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	131.51	202.32	10.12	0.00	0.00	0.00	25.29
Myoblast, donor1	11241-116D8	69.44	37.64	4.97	4.47	0.99	0.12	0.75
Myoblast, donor2	11322-117D8	41.43	24.55	2.11	3.07	1.15	0.00	0.96
Myoblast, donor3	11398-118D3	77.35	44.90	6.39	5.89	2.02	0.00	1.35
NK T cell leukemia cell line:KHYG-1	10777-110G3	21.60	12.99	2.48	0.88	0.44	0.00	0.00
Natural Killer Cells, donor1	11230-116C6	7.38	11.07	0.92	1.85	0.92	0.00	0.31
Natural Killer Cells, donor2	11311-117C6	9.65	12.97	1.51	0.30	0.00	0.00	0.30
Natural Killer Cells, donor3	11387-118C1	15.83	8.47	0.74	0.55	0.18	0.00	0.37
Neural stem cells, donor1	11275-116H6	116.14	99.81	22.14	12.34	0.36	0.00	1.81
Neural stem cells, donor2	11352-117H2	157.90	75.10	9.63	11.55	0.00	0.00	0.00
Neurons, donor1	11494-119E9	99.00	95.58	11.38	15.93	0.00	0.00	6.83
Neurons, donor2	11574-120E8	108.54	86.96	11.23	7.93	1.10	0.00	3.08
Neurons, donor3	11655-122E8	101.13	92.08	14.80	16.44	0.00	0.00	5.76
Neutrophils, donor1	11233-116C9	4.64	2.78	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	8.70	2.90	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	4.89	1.22	0.00	0.00	0.00	0.61	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	79.55	38.95	6.06	3.80	1.19	0.00	0.95
Nucleus Pulposus Cell, donor2	11409-118E5	38.75	21.82	3.26	2.93	0.33	0.00	1.63
Nucleus Pulposus Cell, donor3	11462-119B4	49.54	22.46	4.41	3.21	0.80	0.00	1.80
Olfactory epithelial cells, donor1	11933-125I7	37.03	27.26	2.62	1.65	0.69	0.00	0.28
Olfactory epithelial cells, donor2	11934-125I8	34.30	33.00	3.62	3.47	0.58	0.00	1.88
Olfactory epithelial cells, donor3	11935-125I9	34.51	37.34	2.84	2.84	0.57	0.23	0.34
Olfactory epithelial cells, donor4	11936-126A1	50.65	29.32	3.70	3.21	1.07	0.39	0.39
Oligodendrocyte - precursors, donor1	11496-119F2	263.00	31.29	5.42	4.21	1.81	0.00	1.81
Osteoblast - differentiated, donor1	11276-116H7	61.26	37.43	5.96	3.19	0.64	0.21	0.85
Osteoblast - differentiated, donor2	11353-117H3	41.15	30.86	2.29	3.43	1.14	0.00	3.43
Osteoblast - differentiated, donor3	11425-118G3	34.14	18.62	2.48	3.72	0.00	0.00	0.62
Osteoblast, donor1	11277-116H8	17.98	12.31	2.35	1.76	0.59	0.00	0.39
Osteoblast, donor2	11354-117H4	32.31	34.41	4.92	3.51	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	29.15	27.19	3.20	2.13	0.18	0.18	0.18
Pancreatic stromal cells, donor1	11249-116E7	39.84	24.68	3.96	2.19	0.84	0.00	0.76
Pericytes, donor1	11491-119E6	28.93	12.35	3.67	2.56	0.45	0.11	0.11
Pericytes, donor2	11571-120E5	39.16	22.18	3.85	3.17	0.00	0.00	0.91
Pericytes, donor3	11652-122E5	34.79	20.96	3.26	1.83	1.22	0.00	0.81
Perineurial Cells, donor1	11499-119F5	62.95	51.54	7.01	7.12	0.57	0.00	0.57
Perineurial Cells, donor2	11579-120F4	67.72	30.00	4.14	3.96	1.01	0.00	0.37
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	13.39	14.02	1.91	0.64	0.64	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	6.12	8.08	0.73	0.49	0.24	0.00	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	12.29	12.17	1.04	1.55	0.13	0.26	0.26
Placental Epithelial Cells, donor1	11278-116H9	32.77	26.07	0.72	4.07	1.20	0.24	0.00
Placental Epithelial Cells, donor2	11355-117H5	41.03	32.16	4.44	1.11	1.11	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	34.36	33.77	5.10	3.53	1.18	0.39	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	66.77	29.11	2.85	2.53	1.27	0.00	7.28
Preadipocyte - breast, donor1	11467-119B9	70.72	46.33	7.13	6.00	0.38	0.00	0.94
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	53.91	19.06	1.44	3.92	1.04	0.13	0.26
Preadipocyte - breast, donor2	11328-117E5	71.82	24.09	3.15	4.28	0.90	0.23	3.15
Preadipocyte - omental, donor1	11468-119C1	87.27	56.37	8.42	7.99	1.70	0.64	1.92
Preadipocyte - omental, donor2	11329-117E6	147.53	53.69	8.73	7.86	2.18	1.31	1.31
Preadipocyte - omental, donor3	11403-118D8	107.15	49.71	5.16	7.16	1.00	0.29	1.29
Preadipocyte - perirenal, donor1	11469-119C2	114.18	24.61	3.94	12.80	3.94	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	16.28	10.44	2.46	0.92	0.31	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	38.96	22.67	1.95	1.24	0.89	0.00	2.12
Preadipocyte - subcutaneous, donor3	11428-118G6	45.81	27.59	1.70	4.43	1.87	0.00	0.85
Preadipocyte - visceral, donor1	11280-116I2	38.94	20.12	2.33	2.14	0.93	0.00	0.19
Preadipocyte - visceral, donor2	11357-117H7	37.73	20.25	2.30	0.46	1.84	0.00	1.38
Preadipocyte - visceral, donor3	11429-118G7	28.11	12.12	2.30	3.24	1.04	0.00	0.42
Prostate Epithelial Cells (polarized), donor1	11253-116F2	41.79	42.39	5.13	3.92	0.15	0.00	1.21
Prostate Epithelial Cells, donor2	11331-117E8	21.80	15.44	2.44	2.44	0.95	0.00	0.68
Prostate Epithelial Cells, donor3	11404-118D9	30.25	4.16	0.73	0.67	0.98	0.06	0.86
Prostate Stromal Cells, donor1	11254-116F3	72.90	33.49	4.44	3.08	0.91	0.00	1.59
Prostate Stromal Cells, donor2	11332-117E9	40.16	29.76	4.48	4.12	0.54	0.00	0.54
Prostate Stromal Cells, donor3	11405-118E1	56.41	45.26	6.88	5.84	1.04	0.31	1.56
Renal Cortical Epithelial Cells, donor1	11516-119H4	32.12	13.14	2.19	0.73	0.36	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	59.26	30.50	4.51	3.60	0.42	0.28	0.76
Renal Epithelial Cells, donor1	11517-119H5	22.83	4.06	0.51	0.51	0.51	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	31.30	13.52	2.13	1.42	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	72.20	32.61	6.35	2.96	0.95	0.00	2.22
Renal Glomerular Endothelial Cells, donor1	11514-119H2	26.55	11.57	0.68	0.68	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	56.33	23.45	3.10	2.56	0.67	0.00	0.67
Renal Glomerular Endothelial Cells, donor3	11675-122H1	43.96	30.86	3.77	3.55	0.67	0.22	1.33
Renal Glomerular Endothelial Cells, donor4	11783-124B1	9.98	7.99	0.00	0.67	0.00	0.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	29.27	14.75	1.98	0.88	0.00	0.00	0.22
Renal Mesangial Cells, donor2	11598-120H5	32.60	19.44	2.51	3.13	0.63	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	15.81	8.32	0.83	0.83	0.28	0.00	1.11
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	45.36	18.52	4.56	1.61	0.00	0.00	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	18.13	6.33	2.95	1.69	2.11	0.00	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	28.73	12.34	2.12	2.31	0.96	0.39	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	97.23	29.30	7.00	3.37	1.56	0.52	0.78
Retinal Pigment Epithelial Cells, donor1	11528-119I7	65.38	40.36	8.81	5.40	0.00	0.28	0.85
Retinal Pigment Epithelial Cells, donor2	11608-120I6	16.47	10.29	3.09	1.03	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	62.73	83.80	13.05	5.77	1.25	0.25	1.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	55.19	16.44	1.74	1.47	0.53	0.67	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	33.06	35.74	5.36	1.79	0.00	0.00	1.79
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	26.42	33.57	5.50	0.55	1.10	0.00	1.65
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	22.62	23.78	4.64	1.16	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	51.49	34.20	3.77	3.90	0.91	0.00	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	45.68	39.13	3.48	2.98	0.89	0.00	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	73.28	58.67	5.91	5.02	0.78	0.00	1.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	81.99	52.10	6.33	7.19	0.99	0.00	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	57.92	42.77	5.36	4.20	0.35	0.00	2.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	50.85	40.68	4.62	3.70	0.69	0.00	2.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	43.54	40.11	4.79	2.46	0.27	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	49.47	43.11	4.39	3.93	0.45	0.00	2.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	68.27	47.66	4.66	4.66	0.36	0.00	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	49.92	43.47	4.88	3.01	0.57	0.00	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	53.87	49.26	4.08	5.04	0.32	0.00	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	61.96	44.48	3.54	4.87	0.89	0.00	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	33.26	40.72	4.01	2.49	0.38	0.00	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	45.93	40.25	2.89	3.63	0.28	0.00	1.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	67.27	68.40	6.58	4.89	0.56	0.00	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	47.11	32.78	3.98	3.98	0.80	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	52.86	40.49	3.11	3.31	0.58	0.00	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	60.15	47.74	6.11	4.96	0.95	0.00	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	46.88	36.74	3.31	2.88	0.53	0.00	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	50.74	36.16	3.36	3.92	0.84	0.00	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	55.20	38.96	5.13	2.73	0.51	0.00	1.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	40.84	39.75	3.10	4.38	0.73	0.00	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	47.46	39.73	5.64	2.94	0.61	0.00	1.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	69.44	48.36	4.70	3.90	0.13	0.00	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	42.69	48.12	4.25	3.54	0.71	0.00	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	54.17	38.89	4.96	4.17	1.19	0.00	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	68.75	45.37	3.27	4.21	0.94	0.00	1.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	38.98	46.24	5.60	3.94	1.04	0.00	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	49.11	41.81	6.42	3.32	0.22	0.00	3.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	55.56	38.23	4.80	4.80	0.42	0.00	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	55.31	45.09	5.25	3.90	0.81	0.00	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	49.90	38.49	3.58	3.75	0.51	0.00	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	66.51	42.80	4.43	4.63	0.58	0.00	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	41.09	50.89	4.81	2.41	0.17	0.00	2.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	50.62	41.70	3.43	4.12	0.82	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	57.95	36.77	3.45	3.94	0.00	0.00	2.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	39.03	40.22	5.11	2.90	0.85	0.00	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	61.55	50.01	6.36	3.55	0.59	0.00	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	48.78	43.71	3.47	3.20	0.27	0.00	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	49.50	38.44	5.25	4.70	0.55	0.00	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	54.05	48.57	5.48	3.57	0.24	0.00	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	55.83	58.25	6.45	4.03	0.20	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	48.97	38.52	5.18	4.90	0.66	0.00	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	59.39	58.69	5.59	4.89	1.05	0.00	3.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	50.77	56.51	4.84	5.14	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	52.75	41.12	3.92	5.39	0.86	0.00	1.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	75.25	79.33	9.61	4.95	0.44	0.00	1.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	73.62	57.19	9.13	5.48	1.22	0.00	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	52.44	55.16	5.12	6.33	0.00	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	73.96	66.05	9.50	5.88	1.13	0.00	2.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	85.37	73.39	9.29	5.09	1.50	0.00	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	77.57	61.63	8.74	5.90	1.65	0.00	2.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	71.93	64.67	9.61	4.70	1.07	0.00	3.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	64.30	43.27	9.62	2.40	0.00	0.00	2.40
Schwann Cells, donor1	11498-119F4	21.82	5.64	0.94	1.69	0.19	0.00	0.38
Schwann Cells, donor2	11578-120F3	40.83	3.40	6.80	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	46.66	14.46	1.75	2.19	1.10	0.00	2.19
Sebocyte, donor1	11220-116B5	44.92	12.05	2.74	1.10	0.55	1.64	0.00
Sebocyte, donor2	11301-117B5	17.46	7.81	1.38	0.92	0.00	0.00	0.92
Sebocyte, donor3	11378-118B1	24.94	11.75	1.03	1.03	0.41	0.00	0.21
Sertoli Cells, donor1	11255-116F4	127.56	43.07	8.28	3.31	3.31	0.00	0.00
Sertoli Cells, donor2	11333-117F1	121.45	48.01	8.47	5.65	2.82	0.00	8.47
Skeletal Muscle Cells, donor1	11281-116I3	52.08	53.84	6.60	5.37	0.70	0.00	0.09
Skeletal Muscle Cells, donor2	11358-117H8	20.24	28.19	3.61	3.61	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	40.97	19.23	0.84	0.84	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	47.91	16.18	3.14	3.61	0.63	0.31	0.94
Skeletal Muscle Cells, donor5	11455-119A6	50.39	16.05	1.64	1.93	1.19	0.45	1.78
Skeletal Muscle Cells, donor6	11459-119B1	55.87	12.93	2.31	1.85	1.08	0.00	1.23
Skeletal Muscle Satellite Cells, donor1	11240-116D7	32.38	30.87	5.92	3.40	0.38	0.25	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	36.39	16.55	2.43	2.43	0.14	0.00	2.28
Skeletal Muscle Satellite Cells, donor3	11397-118D2	53.67	24.11	3.67	3.47	0.89	0.10	1.69
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	80.21	71.28	9.94	8.00	0.76	0.08	0.67
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	22.44	17.37	5.79	0.72	0.72	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	23.53	21.19	2.34	3.99	0.41	0.00	0.55
Skin - palm, donor1	10286-104F7	24.17	2.69	0.00	0.00	2.69	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	23.79	11.10	1.59	1.01	0.29	0.43	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	8.18	9.81	1.64	0.82	0.00	2.45	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	17.53	9.22	1.17	0.52	0.52	0.00	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	35.86	19.32	2.09	1.95	0.97	0.14	1.95
Small Airway Epithelial Cells, donor2	11334-117F2	20.40	11.25	1.41	1.55	0.56	0.14	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	39.96	14.59	1.27	2.11	1.48	1.27	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	23.23	7.35	0.97	0.97	1.20	0.07	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	11.73	10.80	2.47	0.62	0.62	0.00	1.85
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	73.59	51.58	9.78	8.45	4.22	0.00	2.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	35.27	21.16	1.76	1.18	0.59	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	36.24	22.54	1.99	2.43	0.88	0.00	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	31.11	12.21	2.76	0.79	1.58	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	43.26	33.22	0.77	3.86	0.77	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	29.02	46.03	1.00	3.00	0.00	0.00	3.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	31.54	28.21	2.93	2.13	0.13	0.00	0.53
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	53.86	43.89	4.65	5.98	0.66	0.22	1.11
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	40.59	29.06	5.76	4.23	1.02	0.13	0.64
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	45.26	37.12	5.86	3.58	0.65	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	75.31	47.55	8.27	5.02	0.89	0.00	1.18
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	70.47	31.75	3.84	3.27	0.85	0.57	1.85
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	22.29	5.86	0.81	1.46	0.16	0.33	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	52.06	17.96	3.04	2.13	0.91	0.00	1.22
Smooth Muscle Cells - Carotid, donor1	11285-116I7	27.02	14.65	2.78	2.27	0.76	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	24.48	36.72	0.00	6.12	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	25.75	9.54	1.43	0.00	0.00	0.00	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	36.28	22.27	1.77	1.47	0.15	0.59	0.88
Smooth Muscle Cells - Colonic, donor2	11320-117D6	27.12	14.85	2.37	1.94	0.22	0.22	1.94
Smooth Muscle Cells - Colonic, donor3	11396-118D1	38.83	23.83	2.62	1.78	0.63	0.63	0.94
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	28.00	12.37	2.32	1.24	0.62	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	28.02	28.02	2.16	1.08	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	26.60	19.72	2.39	3.59	0.90	0.00	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	27.65	5.80	0.34	0.34	0.68	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	64.00	29.37	6.20	2.28	0.55	0.08	0.94
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	38.65	25.26	5.23	3.12	1.01	0.00	1.71
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	75.55	55.75	3.64	7.51	1.82	0.68	1.37
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	28.98	9.06	2.42	1.81	1.21	0.00	1.21
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	80.54	23.31	2.65	3.44	2.65	0.26	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	40.08	22.90	4.26	4.53	2.26	0.27	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	35.44	30.68	3.01	3.26	1.00	0.25	1.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	65.70	48.70	7.10	4.57	1.01	0.00	0.76
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	66.04	28.65	2.71	3.92	2.41	0.00	0.90
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	42.76	14.25	0.00	2.25	1.50	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	93.04	12.92	2.58	5.17	0.00	0.00	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	40.46	14.42	3.72	1.40	0.47	0.00	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	80.28	28.78	3.03	4.54	0.00	0.00	2.02
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	55.78	22.88	0.94	1.88	1.57	0.00	3.13
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	20.65	7.96	2.06	0.59	0.59	0.29	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	57.48	13.00	1.67	1.67	2.25	0.00	0.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	37.37	18.69	2.80	0.93	1.40	0.00	1.40
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	25.62	16.12	3.60	1.87	0.43	0.00	0.43
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	33.40	19.89	3.31	1.78	0.25	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	24.07	15.04	1.50	2.44	0.75	0.00	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	40.39	30.74	6.29	2.79	1.40	0.56	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	65.35	51.36	6.28	8.46	1.17	0.67	0.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	6.19	5.71	1.43	0.00	1.43	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	23.00	16.39	3.91	2.20	0.24	0.24	0.73
Smooth Muscle Cells - Uterine, donor1	11258-116F7	49.49	30.49	5.08	3.09	2.21	0.88	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	17.26	12.58	1.46	0.88	0.59	0.00	1.17
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	24.49	37.90	4.08	2.14	0.78	0.00	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	21.16	29.09	2.38	1.59	0.26	0.00	0.79
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	21.20	24.18	3.35	0.37	0.74	0.00	2.98
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	29.47	37.01	9.34	0.72	0.72	0.72	1.08
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	25.55	21.58	4.54	1.70	0.00	0.00	1.99
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	24.81	18.51	4.33	2.76	0.79	0.39	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	24.13	17.01	4.32	1.27	0.76	0.00	3.05
Smooth muscle cells - airway, control, donor2	11967-126D5	36.74	28.75	5.19	1.20	1.60	0.80	1.20
Smooth muscle cells - airway, control, donor3	11968-126D6	43.05	22.15	2.93	2.51	0.42	0.00	2.93
Smooth muscle cells - airway, control, donor4	11969-126D7	41.71	16.96	1.38	0.46	0.00	0.00	3.21
Synoviocyte, donor1	11291-117A4	57.73	44.44	5.05	3.20	0.50	0.34	0.84
Synoviocyte, donor2	11368-117I9	85.32	37.04	4.53	6.03	1.34	0.00	1.68
Synoviocyte, donor3	11440-118H9	99.42	20.33	2.23	4.24	0.45	0.22	2.23
Trabecular Meshwork Cells, donor1	11532-120A2	24.30	9.29	2.14	0.36	0.71	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	3.96	5.95	0.00	3.96	0.00	1.98	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	13.20	8.80	0.69	0.23	1.16	0.23	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	16.63	5.59	1.15	0.57	0.14	0.43	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	18.56	5.03	0.00	0.39	0.00	0.39	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	14.89	1.72	0.57	0.00	0.57	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	57.45	14.89	1.85	1.85	0.49	0.62	0.12
Urethra, donor2	10319-105A4	39.57	10.79	3.60	3.60	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	20.19	7.70	2.13	1.86	0.80	0.53	0.27
Urothelial Cells, donor2	11600-120H7	14.42	10.41	0.00	0.40	0.80	0.40	0.40
Urothelial Cells, donor3	11681-122H7	14.90	5.04	0.69	0.92	0.69	0.46	0.23
Urothelial cells, donor0	11216-116B1	36.11	17.61	2.67	2.23	0.67	0.45	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	18.69	3.56	0.89	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	12.87	2.86	1.43	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	9.58	2.74	0.68	0.00	0.00	0.00	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	13.77	9.64	1.72	0.69	0.00	0.00	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	12.20	13.94	2.32	0.58	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	11.45	3.12	1.04	1.04	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	9.18	4.59	0.00	0.00	0.00	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	9.13	0.91	0.00	0.00	0.00	0.00	0.91
Wilms' tumor cell line:G-401	10809-111A8	39.35	52.68	5.30	5.80	0.74	0.00	1.23
Wilms' tumor cell line:HFWT	10597-108E3	15.84	18.48	0.88	3.52	0.88	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	8.66	0.56	0.28	0.00	0.56	0.00	0.28
achilles tendon, donor2	10292-104G4	18.60	6.20	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	48.95	27.54	4.59	1.27	0.76	0.25	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	28.56	50.61	7.20	3.02	0.70	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	36.09	41.31	7.72	1.90	0.36	0.00	0.47
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	28.03	27.76	4.08	3.54	0.54	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	53.41	64.09	7.87	4.50	0.28	0.00	2.81
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	54.77	65.35	5.29	4.02	1.69	0.00	0.85
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	17.42	37.29	6.53	1.63	0.54	0.00	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	33.93	35.25	4.41	4.85	0.00	0.00	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	41.65	41.65	2.04	2.04	0.00	0.00	1.23
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	54.36	42.32	3.11	4.27	0.39	0.00	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	26.86	8.46	1.10	0.74	0.55	0.00	1.29
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	39.01	19.50	7.80	0.00	0.00	0.00	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	21.15	56.00	6.97	2.79	0.23	0.00	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	22.27	22.01	1.55	0.52	0.78	0.78	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	27.18	20.46	2.05	0.88	2.63	0.29	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	20.91	9.30	1.39	0.46	0.93	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	11.52	24.68	5.35	1.23	0.00	0.00	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	40.82	10.44	0.31	0.00	0.92	0.00	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	46.51	11.09	0.43	2.13	1.71	0.00	1.28
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	46.71	14.86	0.00	1.21	1.82	0.00	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	55.60	14.44	0.72	0.96	1.44	0.00	0.96
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	36.08	15.15	1.78	1.11	1.11	0.00	1.11
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	21.01	5.00	0.00	0.67	0.67	0.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	14.87	14.87	0.00	1.86	1.86	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	19.96	27.87	4.52	1.13	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	12.21	32.27	6.11	3.49	0.44	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	20.62	26.24	0.00	0.00	3.75	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	84.78	4.00	0.24	0.47	1.88	0.47	0.24
adipose tissue, adult, pool1	10010-101C1	75.85	23.89	2.64	4.50	1.24	0.00	0.62
adipose, donor1	10184-103D4	110.83	108.49	15.83	9.38	0.00	0.59	7.62
adipose, donor2	10185-103D5	62.45	68.94	15.82	5.68	2.43	0.00	1.22
adipose, donor3	10186-103D6	67.26	65.35	14.98	5.17	1.09	0.00	1.36
adipose, donor4	10187-103D7	29.47	32.07	2.60	5.20	1.73	0.00	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	48.61	9.63	0.63	0.79	6.00	0.00	0.16
adrenal gland, adult, pool1	10081-102A9	43.65	36.38	3.64	10.91	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	19.08	3.34	0.53	0.13	1.07	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	29.30	38.59	2.86	1.43	1.79	0.00	1.07
amniotic membrane cells, donor1	12235-129G3	50.31	5.80	0.93	0.46	2.09	0.46	0.23
amniotic membrane cells, donor2	12236-129G4	105.15	38.88	5.41	4.73	1.35	0.00	1.01
amniotic membrane cells, donor3	12237-129G5	48.61	5.89	1.47	1.77	2.06	0.00	0.29
amygdala - adult, donor10196	10167-103B5	80.63	112.65	26.09	15.42	3.56	7.11	4.74
amygdala, adult, donor10252	10151-102I7	181.07	67.32	9.53	9.73	1.42	5.07	3.85
amygdala, newborn, donor10223	10360-105E9	75.21	40.99	9.68	4.84	0.65	1.61	2.58
anaplastic carcinoma cell line:8305C	10428-106D5	33.11	43.55	6.88	2.93	1.15	0.00	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	33.31	16.33	2.21	3.97	1.10	0.00	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	101.21	89.52	8.68	4.68	0.00	0.33	0.67
aorta, adult, pool1	10052-101G7	78.85	23.73	2.16	1.57	1.57	0.20	1.18
appendix, adult	10189-103D9	78.79	14.75	0.00	0.78	1.16	0.00	1.94
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	42.99	65.35	4.82	3.10	0.00	2.06	0.00
artery, adult	10190-103E1	141.30	16.30	4.08	4.08	2.72	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	70.26	110.68	12.17	6.95	0.72	1.01	1.45
b cell line:RPMI1788	10427-106D4	29.00	18.14	3.27	1.78	0.30	0.45	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	59.10	53.27	4.99	5.55	0.83	0.00	2.50
bile duct carcinoma cell line:HuCCT1	10432-106D9	44.46	20.14	3.97	1.39	0.99	0.30	0.50
bile duct carcinoma cell line:TFK-1	10496-107C1	94.57	4.69	0.00	1.00	2.34	0.17	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	16.78	11.18	0.56	1.12	0.56	0.56	0.00
bladder, adult, pool1	10011-101C2	41.72	13.91	1.20	1.96	1.09	0.11	0.54
blood, adult, pool1	10053-101G8	4.43	8.86	4.43	2.21	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	28.26	13.70	3.43	0.86	2.57	0.00	0.86
bone marrow, adult	10192-103E3	122.82	42.51	3.37	4.05	0.67	0.00	6.75
brain, adult, donor1	10084-102B3	108.66	97.38	17.43	25.63	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	105.79	67.82	11.58	9.47	3.23	1.00	1.34
brain, fetal, pool1	10085-102B4	106.86	93.50	16.03	13.36	0.00	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	16.85	3.30	0.33	0.00	0.33	0.00	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	2.25	0.37	0.12	0.00	0.00	0.00	0.00
breast, adult, donor1	10080-102A8	114.28	21.47	1.26	3.16	0.63	0.00	3.16
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	122.97	13.47	1.65	2.54	2.16	0.00	2.29
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	66.17	40.51	3.71	4.33	3.71	0.31	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	16.35	5.06	0.69	0.23	1.38	0.00	0.69
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	25.42	22.03	2.42	1.69	0.48	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	90.74	54.07	9.87	5.64	0.94	2.82	2.82
carcinoid cell line:NCI-H727	10735-110B6	67.49	19.25	2.95	3.06	1.09	2.08	0.55
carcinoid cell line:SK-PN-DW	10719-109I8	42.15	43.73	3.80	2.54	0.95	0.63	1.27
carcinosarcoma cell line:JHUCS-1	10642-109A3	67.08	78.52	10.38	8.25	1.06	0.00	3.19
caudate nucleus - adult, donor10196	10177-103C6	100.17	90.95	14.97	12.66	1.15	2.30	0.00
caudate nucleus, adult, donor10252	10164-103B2	145.24	69.94	12.72	9.04	1.84	2.84	4.18
caudate nucleus, adult, donor10258	10379-105H1	90.93	100.87	24.45	9.17	0.76	2.29	0.00
caudate nucleus, newborn, donor10223	10354-105E3	90.09	52.37	15.75	2.93	0.00	0.00	2.56
cerebellum - adult, donor10196	10173-103C2	84.48	104.88	17.48	8.74	0.00	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	111.24	67.26	7.69	7.26	1.07	0.85	1.28
cerebellum, adult, pool1	10083-102B2	103.83	70.37	9.66	6.90	1.38	0.34	2.07
cerebellum, newborn, donor10223	10357-105E6	78.88	46.50	15.78	1.66	0.00	0.00	0.83
cerebral meninges, adult	10188-103D8	114.72	54.46	10.09	4.79	1.76	0.50	3.78
cerebrospinal fluid, donor2	10294-104G6	65.05	15.35	2.92	0.00	0.73	1.46	1.46
cervical cancer cell line:D98-AH2	10552-107I3	57.08	34.65	6.47	3.02	0.72	0.00	0.29
cervical cancer cell line:ME-180	10553-107I4	193.56	42.26	6.79	5.14	3.48	2.49	0.33
cervix, adult, pool1	10013-101C4	47.98	37.27	5.35	4.20	1.15	0.00	0.52
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	114.40	48.07	6.69	5.99	1.39	0.00	1.67
chondrosarcoma cell line:SW 1353	10700-109G7	15.68	14.37	1.31	1.31	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	23.12	35.17	9.32	2.24	0.87	0.00	0.50
choriocarcinoma cell line:SCH	10785-110H2	44.85	23.78	3.08	1.36	0.25	0.00	0.74
choriocarcinoma cell line:T3M-3	10618-108G6	33.44	15.65	4.27	2.13	0.24	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	28.78	3.70	0.28	0.28	0.85	0.00	0.57
chorionic membrane cells, donor2	12239-129G7	35.80	32.51	4.57	3.88	0.40	0.20	0.20
chorionic membrane cells, donor3	12240-129G8	13.19	3.85	0.00	1.10	0.55	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	6.06	30.29	9.09	1.01	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	34.77	34.00	4.61	3.07	0.77	0.00	0.77
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	19.64	12.25	2.11	1.27	0.63	0.00	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	12.84	10.27	0.00	1.03	0.77	0.00	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	15.00	10.16	0.97	1.69	0.48	0.24	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	15.88	9.16	1.02	1.22	0.00	0.00	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	25.91	16.49	1.18	1.18	0.00	0.00	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	33.36	20.59	3.13	0.78	1.04	0.52	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	35.66	15.09	2.29	1.60	2.29	0.00	1.60
clear cell carcinoma cell line:TEN	10636-108I6	93.17	30.36	6.59	4.51	1.56	0.17	2.08
colon carcinoma cell line:CACO-2	10513-107D9	91.34	71.02	10.62	5.86	1.28	0.00	0.18
colon carcinoma cell line:COLO-320	10420-106C6	89.70	59.29	6.08	5.70	0.38	1.90	1.52
colon, adult, donor1	10082-102B1	184.45	27.37	5.95	3.57	1.19	1.19	0.00
colon, adult, pool1	10014-101C5	167.09	13.28	5.76	2.00	1.76	0.12	0.59
colon, fetal, donor1	10070-101I7	261.41	29.66	6.18	5.56	4.33	0.62	0.62
common myeloid progenitor CMP, donor1	12130-128D6	96.25	41.25	0.00	0.00	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	125.18	100.15	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	23.37	9.77	1.27	2.12	0.85	0.00	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	28.83	15.40	1.21	0.75	0.15	0.00	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	32.86	16.22	1.97	2.12	0.85	0.00	0.28
corpus callosum, adult, pool1	10042-101F6	197.57	72.86	9.18	11.06	4.64	2.87	0.77
cruciate ligament, donor2	10295-104G7	32.42	12.16	0.81	0.81	0.81	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	127.61	42.54	3.21	4.82	0.00	0.00	1.61
diencephalon, adult	10193-103E4	134.87	43.92	10.32	8.16	0.96	0.72	3.36
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	28.01	23.65	5.97	2.30	0.46	1.15	1.84
ductal cell carcinoma cell line:KLM-1	10438-106E6	52.06	28.46	6.15	1.54	0.77	0.26	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	38.76	10.59	0.72	1.44	0.00	0.00	0.72
ductus deferens, adult	10196-103E7	308.47	25.91	1.99	1.50	2.49	0.50	10.47
duodenum, fetal, donor1, tech_rep1	10071-101I8	233.32	51.85	2.88	2.88	0.00	1.44	5.76
duodenum, fetal, donor1, tech_rep2	10071-101I8	186.85	28.69	4.41	1.47	2.94	0.00	12.51
dura mater, adult, donor1	10041-101F5	92.58	28.33	3.88	3.14	1.57	0.00	0.66
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	51.52	53.96	11.99	3.55	0.44	2.44	1.33
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	131.83	60.47	10.75	7.16	0.72	3.15	0.72
embryonic pancreas cell line:1B2C6	10604-108F1	15.42	17.27	0.62	1.85	1.23	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	27.85	26.03	3.03	2.42	1.21	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	21.61	21.30	2.16	2.78	2.78	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	23.64	15.76	1.31	2.63	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	38.88	52.29	5.70	4.02	0.34	0.67	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	43.86	15.22	2.90	1.27	2.72	0.00	0.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	51.78	20.91	1.77	1.29	0.32	0.16	4.02
epidermoid carcinoma cell line:A431	10426-106D3	51.69	9.89	1.00	1.00	1.11	0.00	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	38.27	24.75	4.51	2.53	1.10	0.00	0.33
epididymis, adult	10197-103E8	129.35	24.91	3.35	2.30	1.26	0.00	5.65
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	23.06	6.74	0.71	0.71	1.77	0.00	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	18.88	8.26	1.18	1.18	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	55.04	10.62	1.18	1.31	1.18	0.00	3.15
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	43.50	14.37	0.98	1.57	1.18	0.00	1.28
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	53.66	12.32	1.79	2.24	1.01	0.00	1.12
esophagus, adult, pool1	10015-101C6	39.18	8.92	1.27	1.06	0.85	0.21	0.85
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	55.86	26.55	3.38	3.13	1.25	0.00	0.13
eye - muscle inferior rectus, donor1	10272-104E2	38.63	28.97	2.41	7.24	4.83	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	27.35	23.15	0.00	0.00	0.00	0.00	2.10
eye - muscle medial, donor2	10299-104H2	78.88	23.81	0.00	4.46	0.00	0.00	1.49
eye - muscle superior, donor2	10297-104G9	53.89	30.96	2.29	0.00	1.15	0.00	1.15
eye - vitreous humor, donor1	10268-104D7	20.40	11.66	0.00	2.91	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	160.93	108.30	20.59	10.42	3.31	0.00	3.31
fibrosarcoma cell line:HT-1080	10758-110E2	39.11	18.08	3.59	2.95	1.41	0.00	0.51
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	25.40	14.72	2.61	2.37	1.19	0.24	0.00
frontal lobe, adult, pool1	10040-101F4	138.86	92.14	15.20	12.20	1.97	3.28	1.03
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	15.01	3.00	0.30	0.90	0.30	0.00	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	29.72	24.32	3.29	4.02	1.65	0.00	0.64
gall bladder, adult	10198-103E9	137.86	15.93	1.93	0.97	1.93	0.00	3.14
gamma delta positive T cells, donor1	11937-126A2	12.35	12.88	1.61	0.54	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	11.20	22.04	1.49	0.75	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	46.47	39.08	6.34	3.38	0.21	0.42	2.11
gastric adenocarcinoma cell line:MKN45	10612-108F9	210.44	11.99	1.35	2.90	1.93	0.00	2.71
gastric cancer cell line:AZ521	10549-107H9	66.89	43.45	4.92	3.93	1.15	0.00	0.66
gastric cancer cell line:GSS	10560-108A2	28.37	5.49	0.00	2.75	1.83	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	86.59	28.79	4.11	1.60	0.00	0.69	2.74
giant cell carcinoma cell line:LU65	10487-107B1	26.05	6.43	1.15	0.80	0.80	0.00	0.80
giant cell carcinoma cell line:Lu99B	10433-106E1	71.66	19.59	2.66	1.96	1.96	0.00	0.70
glassy cell carcinoma cell line:HOKUG	10688-109F4	62.11	20.20	1.25	1.50	2.99	0.00	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	41.80	22.27	2.74	2.01	0.95	0.00	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	52.10	22.05	4.07	3.23	0.70	0.00	0.42
glioblastoma cell line:T98G	10485-107A8	33.77	47.79	5.19	2.76	1.21	0.00	0.11
glioma cell line:GI-1	10413-106B8	70.29	82.01	14.06	5.56	0.59	0.00	1.17
globus pallidus - adult, donor10196	10175-103C4	99.13	86.01	14.58	10.93	1.46	5.10	2.19
globus pallidus, adult, donor10252	10161-103A8	200.16	52.72	6.35	7.81	1.71	4.15	2.20
globus pallidus, adult, donor10258	10367-105F7	64.35	53.40	2.74	6.85	4.11	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	106.05	37.30	10.13	2.66	1.07	1.60	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	134.59	22.02	2.45	2.45	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	87.43	21.86	0.00	10.93	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	94.08	52.27	10.45	5.23	0.00	0.00	5.23
granulosa cell tumor cell line:KGN	10624-108H3	29.44	40.64	4.16	3.20	0.64	0.64	1.28
hIPS +CCl2, biol_rep1	14383-156B9	23.41	21.58	5.05	0.92	0.46	0.46	0.92
hIPS +CCl2, biol_rep2	14384-156C1	14.63	21.95	5.03	1.83	0.46	0.00	0.91
hIPS +CCl2, biol_rep3	14385-156C2	15.46	27.70	5.80	1.29	0.64	0.00	0.00
hIPS, biol_rep1	14380-156B6	11.50	33.06	8.62	1.44	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	13.03	29.49	3.43	0.00	0.69	0.00	0.00
hIPS, biol_rep3	14382-156B8	50.76	90.48	12.14	7.72	3.31	4.41	0.00
hairy cell leukemia cell line:Mo	10712-109I1	9.19	6.03	0.00	0.29	0.29	0.00	0.00
heart - mitral valve, adult	10205-103F7	30.79	28.40	1.79	6.88	0.60	0.00	0.60
heart - pulmonic valve, adult	10206-103F8	28.50	18.30	0.26	2.09	1.57	0.52	0.52
heart - tricuspid valve, adult	10207-103F9	35.80	18.32	0.83	0.00	2.50	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	44.48	16.32	2.24	1.63	1.22	0.00	0.61
heart, adult, diseased, donor1	10051-101G6	56.21	21.72	2.55	4.26	0.85	0.43	0.85
heart, adult, pool1	10016-101C7	36.11	17.94	1.38	1.84	0.23	0.23	0.23
heart, fetal, pool1	10046-101G1	55.86	70.44	10.06	5.85	1.03	0.21	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	49.67	35.79	4.01	3.39	2.47	0.00	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	51.13	11.89	3.57	1.19	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	60.11	35.25	5.08	3.43	0.44	0.22	0.88
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	70.28	33.38	4.61	3.16	1.09	0.24	0.85
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	64.78	35.87	3.33	3.44	1.01	0.20	1.11
hepatoma cell line:Li-7	10484-107A7	88.53	25.91	1.33	1.78	0.44	0.00	1.56
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	36.78	22.81	5.73	1.41	0.70	0.00	0.10
hippocampus - adult, donor10196	10169-103B7	88.01	93.69	8.52	13.25	0.00	6.62	0.95
hippocampus, adult, donor10252	10153-102I9	201.45	61.43	8.16	8.78	1.43	3.67	4.29
hippocampus, adult, donor10258	10374-105G5	41.33	67.72	12.45	4.98	3.98	3.49	1.49
hippocampus, newborn, donor10223	10363-105F3	76.14	43.71	9.16	4.93	0.70	0.70	1.76
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	36.01	25.02	7.32	0.61	0.61	0.00	4.27
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	27.49	17.08	4.71	1.77	0.39	0.39	1.77
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	25.64	15.74	4.82	0.51	0.25	0.51	1.78
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	74.99	50.18	7.89	3.38	0.00	0.00	4.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	92.44	46.22	11.36	4.13	0.77	0.26	13.17
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	72.51	53.15	12.15	2.28	1.14	0.76	5.31
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	56.06	53.72	9.34	1.46	1.46	0.29	5.26
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	75.83	51.06	11.20	4.52	0.43	0.22	3.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	57.14	47.13	13.35	2.09	0.00	0.83	2.92
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	86.90	106.56	15.63	8.29	0.71	0.47	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	70.39	67.66	10.61	6.11	0.96	0.00	4.02
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	92.92	103.69	19.53	7.41	0.67	0.67	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	23.32	18.31	4.85	2.35	0.63	0.00	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	23.09	17.20	3.93	0.00	1.97	0.00	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	23.56	23.56	10.47	1.75	0.87	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	80.95	78.85	18.14	5.73	0.95	0.57	2.10
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	58.00	70.21	9.59	5.67	2.18	0.87	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	54.97	78.46	18.49	3.50	1.50	0.00	1.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	56.33	61.79	15.45	6.22	2.07	0.19	1.51
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	63.66	72.75	16.37	5.46	2.27	0.00	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	49.49	65.47	20.99	2.82	3.13	0.00	1.25
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	57.65	116.92	23.68	8.98	0.65	0.33	3.43
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	51.09	109.74	23.22	11.32	1.45	0.00	1.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	46.33	92.67	20.92	5.08	0.60	0.00	2.39
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	26.60	22.91	4.06	2.40	1.11	0.74	1.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	32.81	28.53	2.28	1.43	0.29	0.57	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	31.03	31.03	5.31	1.22	0.82	0.00	1.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	53.52	57.04	12.32	3.52	1.06	0.70	5.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	52.90	54.48	10.14	5.38	2.22	0.95	1.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	49.93	60.83	10.89	2.42	0.61	0.61	3.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	54.81	77.05	17.07	9.83	2.07	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	60.44	81.69	17.93	2.66	0.00	0.00	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	32.32	64.39	14.62	2.31	0.26	0.51	1.54
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	44.23	96.12	18.92	9.20	0.77	0.26	2.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	65.88	146.14	24.99	11.36	1.51	0.00	5.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	40.66	94.77	21.51	4.37	0.67	0.00	2.69
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	31.15	22.70	5.31	2.42	0.24	0.00	0.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	19.61	17.83	6.68	0.45	0.00	0.00	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	21.95	27.32	3.41	0.49	1.95	0.49	1.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	62.35	51.04	11.31	3.06	0.31	0.31	0.92
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	100.85	195.19	42.29	9.76	9.76	3.25	42.29
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	54.94	68.17	16.88	3.97	0.00	0.33	1.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	54.73	59.11	12.59	6.57	4.93	0.00	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	44.51	46.32	10.13	3.98	1.45	0.00	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	34.16	50.89	11.74	2.14	1.07	0.00	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	38.19	82.34	14.32	5.97	2.39	0.00	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	69.34	124.59	16.79	6.77	1.35	0.54	1.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	33.14	77.86	12.39	3.50	1.08	0.27	1.08
immature langerhans cells, donor1	11904-125F5	13.32	5.33	0.97	0.24	0.97	0.00	0.00
immature langerhans cells, donor2	11905-125F6	13.47	4.75	0.79	0.00	0.00	0.00	0.79
insula, adult, pool1	10039-101F3	146.40	100.97	18.17	14.57	1.42	2.93	0.66
keratoacanthoma cell line:HKA-1	10791-110H8	12.03	5.20	0.65	0.00	0.33	0.00	0.33
kidney, adult, pool1	10017-101C8	103.73	44.76	3.40	4.81	1.60	1.30	1.30
kidney, fetal, pool1	10045-101F9	85.31	67.98	10.12	7.57	1.13	0.57	0.42
large cell lung carcinoma cell line:IA-LM	10509-107D5	43.46	87.91	13.92	9.23	0.43	0.00	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	20.32	51.29	7.47	2.63	1.11	0.00	1.52
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	25.87	9.91	1.28	1.65	0.37	0.00	0.37
left atrium, adult, donor1	10079-102A7	49.58	40.86	6.54	3.81	2.18	0.00	0.00
left ventricle, adult, donor1	10078-102A6	31.35	32.87	2.02	3.03	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	30.10	10.94	0.27	2.46	0.82	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	61.79	45.62	7.54	6.47	3.23	0.00	8.62
leiomyoma cell line:15242A	10570-108B3	58.70	36.96	5.98	5.98	3.80	0.00	5.98
leiomyoma cell line:15425	10571-108B4	36.91	39.34	5.34	3.89	1.94	0.00	1.70
leiomyosarcoma cell line:Hs 5.T	10722-110A2	82.54	95.24	6.35	12.70	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	56.46	30.32	1.05	0.00	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	50.53	22.90	4.13	2.13	0.47	0.00	0.24
liposarcoma cell line:KMLS-1	10782-110G8	33.27	34.68	6.40	1.09	2.19	0.00	0.47
liposarcoma cell line:SW 872	10726-110A6	68.11	56.66	6.82	6.58	0.49	0.00	1.22
liver, adult, pool1	10018-101C9	25.61	8.43	1.30	1.13	0.65	0.00	0.16
liver, fetal, pool1	10086-102B5	34.81	15.05	1.88	1.88	0.00	0.00	0.94
locus coeruleus - adult, donor10196	10182-103D2	95.95	64.31	10.21	8.90	3.06	2.92	0.29
locus coeruleus, adult, donor10252	10165-103B3	158.53	62.38	7.94	10.89	2.40	2.95	3.88
locus coeruleus, adult, donor10258	10375-105G6	131.76	104.11	16.08	11.85	1.97	3.95	5.08
locus coeruleus, newborn, donor10223	10362-105F2	96.32	32.81	6.73	2.52	1.26	0.42	2.94
lung adenocarcinoma cell line:A549	10499-107C4	42.21	23.53	2.91	1.66	1.66	0.69	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	39.30	6.89	2.76	1.38	0.00	0.69	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	111.12	14.90	1.32	1.85	1.85	0.00	1.45
lung, adult, pool1	10019-101D1	141.40	15.00	1.30	1.54	2.01	0.59	0.71
lung, fetal, donor1	10068-101I5	83.91	65.93	13.41	8.56	5.99	1.14	0.29
lung, right lower lobe, adult, donor1	10075-102A3	127.84	11.91	0.46	2.75	3.67	0.00	4.58
lymph node, adult, donor1	10077-102A5	35.50	32.66	5.68	3.31	0.47	0.00	0.95
lymphangiectasia cell line:DS-1	10727-110A7	77.59	29.37	1.53	2.19	0.44	0.00	1.32
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	105.50	60.22	8.00	2.57	0.30	0.15	4.08
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	50.97	15.29	4.25	0.85	0.85	0.00	0.00
mature adipocyte, donor1	12231-129F8	376.06	90.13	8.44	23.53	2.22	1.33	0.89
mature adipocyte, donor2	12232-129F9	480.01	58.32	4.77	14.94	2.08	0.21	5.40
mature adipocyte, donor3	12233-129G1	418.42	67.56	7.59	16.36	3.32	1.19	3.08
mature adipocyte, donor4	12234-129G2	287.96	75.54	7.63	19.21	3.16	1.58	1.58
maxillary sinus tumor cell line:HSQ-89	10414-106B9	50.99	14.77	1.19	1.67	2.62	0.00	0.71
medial frontal gyrus - adult, donor10196	10170-103B8	82.35	67.68	12.41	3.38	2.26	3.38	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	136.09	49.65	7.36	7.36	0.74	2.21	2.21
medial frontal gyrus, adult, donor10258	10368-105F8	72.12	76.88	15.88	16.52	1.27	2.86	1.27
medial frontal gyrus, newborn, donor10223	10352-105E1	61.41	37.10	9.81	3.84	1.71	0.43	8.96
medial temporal gyrus - adult, donor10196	10183-103D3	94.33	79.31	16.37	11.14	1.69	4.05	3.71
medial temporal gyrus, adult, donor10252	10156-103A3	127.97	58.36	7.22	7.22	1.06	2.12	2.76
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	32.75	98.24	9.63	9.63	1.93	5.78	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	129.18	258.37	28.71	14.35	0.00	14.35	28.71
medial temporal gyrus, newborn, donor10223	10353-105E2	77.89	51.69	14.36	3.23	1.79	0.36	2.15
medulla oblongata - adult, donor10196	10174-103C3	118.11	74.63	14.28	7.79	3.24	1.95	2.60
medulla oblongata, adult, donor10252	10155-103A2	158.36	54.80	5.88	8.67	2.32	3.56	2.63
medulla oblongata, adult, pool1	10038-101F2	184.40	67.34	9.47	10.04	2.12	2.86	1.06
medulla oblongata, newborn, donor10223	10361-105F1	133.32	38.88	9.03	4.86	1.04	0.00	1.74
medulloblastoma cell line:D283 Med	10838-111E1	59.34	80.37	6.64	5.54	1.99	0.00	1.11
medulloblastoma cell line:ONS-76	10759-110E3	73.12	18.34	2.32	2.81	0.86	0.00	0.24
melanoma cell line:COLO 679	10514-107E1	85.24	31.62	6.18	3.31	1.15	0.00	1.87
melanoma cell line:G-361	10465-106H6	64.61	58.09	12.49	6.79	1.36	0.00	0.27
meningioma cell line:HKBMM	10691-109F7	50.83	15.02	2.17	2.17	2.17	0.00	3.62
merkel cell carcinoma cell line:MKL-1	10843-111E6	55.51	76.66	9.69	7.05	0.00	0.00	2.64
merkel cell carcinoma cell line:MS-1	10844-111E7	55.47	57.29	5.96	7.78	0.52	2.85	1.04
mesenchymal precursor cell - adipose, donor1	11747-123G1	50.63	13.96	1.84	2.92	1.38	0.00	0.46
mesenchymal precursor cell - adipose, donor2	11748-123G2	26.90	20.90	3.45	3.45	0.91	0.00	1.09
mesenchymal precursor cell - adipose, donor3	11749-123G3	27.33	14.08	2.07	4.56	2.07	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	39.75	24.16	3.51	3.51	0.84	0.00	0.84
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	50.65	31.58	4.43	6.74	0.96	0.19	0.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	39.56	37.48	2.78	3.47	0.00	0.00	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	52.69	26.77	4.81	3.26	1.89	0.34	0.69
mesenchymal precursor cell - cardiac, donor2	11753-123G7	54.86	17.48	2.30	3.45	1.27	0.00	1.04
mesenchymal precursor cell - cardiac, donor3	11754-123G8	47.35	16.71	2.25	3.45	0.27	0.00	1.46
mesenchymal precursor cell - cardiac, donor4	11755-123G9	60.09	23.09	3.78	4.46	1.22	0.00	1.35
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	49.37	25.04	3.56	3.41	0.57	0.57	1.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	25.36	24.04	2.63	2.63	0.99	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	39.57	21.86	2.35	3.87	0.42	0.00	0.97
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	33.16	17.45	4.19	2.09	0.00	0.00	1.05
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	56.96	20.21	3.06	3.67	1.02	0.41	0.82
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	19.05	21.21	1.44	2.52	0.00	0.00	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	71.79	26.07	2.79	5.69	1.34	0.00	0.93
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	49.47	33.29	3.42	4.33	0.68	0.00	1.14
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	58.74	31.05	7.13	5.03	2.94	0.42	1.68
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	29.44	18.23	2.39	3.29	1.49	0.00	0.60
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	53.74	29.85	3.06	4.20	0.96	0.09	1.58
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	41.23	28.72	3.68	2.21	0.00	0.00	1.84
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	19.74	24.04	4.01	3.15	0.29	0.00	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	86.73	34.94	6.32	4.21	1.68	0.42	7.16
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	31.51	13.70	1.83	1.37	0.91	0.00	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	32.23	13.81	1.79	1.28	1.02	0.00	1.53
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	34.81	19.37	1.31	2.62	1.05	0.00	1.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	26.19	13.86	2.77	1.85	0.31	0.00	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	28.24	10.36	1.65	1.18	0.47	0.00	2.82
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	29.45	15.23	2.37	2.71	1.69	0.00	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	44.80	16.11	1.96	1.57	0.79	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	27.34	11.12	1.39	0.46	0.00	0.00	1.85
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	32.01	12.98	2.60	0.87	0.87	0.00	1.73
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	39.27	14.50	2.90	3.79	1.34	0.00	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	35.09	17.79	1.68	1.92	0.96	0.00	0.96
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	33.00	11.73	0.00	0.73	0.00	0.00	1.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	25.51	10.74	2.01	0.00	0.67	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	30.29	18.01	2.46	1.64	0.82	0.41	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	33.08	13.75	0.86	1.72	1.29	0.43	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	27.34	16.41	5.47	0.00	2.73	0.00	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	30.99	5.16	0.00	0.00	0.00	0.00	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	31.18	12.99	2.92	0.65	0.65	0.00	1.62
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	33.46	11.64	2.91	1.45	1.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	37.32	18.12	2.13	1.07	1.07	0.00	2.67
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	22.90	15.54	0.00	0.00	0.00	0.00	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	19.82	15.16	1.55	2.33	0.00	0.39	1.94
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	33.58	10.49	4.20	0.00	0.00	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	27.82	16.89	2.98	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	23.84	23.84	4.77	4.77	0.00	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	30.24	9.49	0.59	0.00	0.59	0.59	1.78
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	25.59	26.81	0.00	2.44	0.00	0.00	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00	0.00	27.05
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	31.04	18.37	0.63	0.63	0.63	0.00	3.80
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	29.66	22.07	2.41	1.03	0.34	0.00	2.76
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	32.24	19.34	0.00	6.45	2.15	0.00	4.30
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	31.93	23.95	0.00	3.99	3.99	0.00	7.98
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	30.99	17.22	0.00	3.44	0.00	0.00	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	31.38	18.74	2.44	2.04	0.00	0.00	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	30.19	26.22	0.00	0.79	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	31.83	25.35	1.18	2.95	0.00	0.00	2.95
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	34.91	18.39	4.05	4.05	0.31	0.00	1.25
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	46.78	26.73	1.34	4.01	1.34	0.00	2.67
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	86.34	33.11	2.37	2.37	0.00	0.00	9.46
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	100.15	46.22	0.00	0.00	0.00	0.00	15.41
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	108.77	35.11	3.44	5.51	1.38	0.00	7.57
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	261.75	73.73	7.42	19.30	4.95	1.48	7.92
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	251.22	67.29	3.36	23.55	1.12	1.12	11.22
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	253.79	73.78	7.63	27.35	1.27	1.27	8.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	497.28	104.37	8.46	28.21	3.63	4.84	14.10
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	475.37	100.31	13.08	19.63	2.18	0.00	23.99
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	462.48	117.84	12.67	20.27	3.80	5.07	15.20
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	323.47	65.54	3.64	21.85	0.61	1.82	8.50
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	366.04	94.90	13.56	18.08	4.52	4.52	54.23
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	354.18	74.13	9.88	17.30	2.47	4.12	12.36
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	211.13	59.33	6.15	10.72	1.59	0.79	3.97
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	183.34	44.13	4.87	10.38	0.97	2.27	4.22
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	173.17	45.84	1.02	6.11	1.02	0.00	5.09
mesodermal tumor cell line:HIRS-BM	10696-109G3	60.35	30.17	3.87	2.32	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	45.83	14.88	1.89	3.07	1.42	0.00	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	188.35	47.96	6.72	7.18	1.16	1.62	1.62
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	34.19	34.19	12.82	4.27	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	26.72	34.42	5.65	2.16	0.31	0.00	2.06
mesothelioma cell line:Mero-25	10850-111F4	36.31	35.40	5.90	3.86	0.68	0.00	0.91
mesothelioma cell line:Mero-41	10851-111F5	67.72	26.16	4.16	2.20	1.22	0.00	2.44
mesothelioma cell line:Mero-48a	10852-111F6	21.26	40.52	4.65	1.33	0.44	0.00	0.89
mesothelioma cell line:Mero-82	10853-111F7	34.43	38.90	4.20	4.20	0.26	0.26	1.05
mesothelioma cell line:Mero-83	10854-111F8	37.28	40.17	3.74	2.38	0.51	0.00	0.68
mesothelioma cell line:Mero-84	10855-111F9	142.56	36.90	6.07	5.56	1.77	1.26	2.53
mesothelioma cell line:Mero-95	10856-111G1	95.86	52.17	11.39	5.80	1.66	0.21	2.48
mesothelioma cell line:NCI-H2052	10847-111F1	34.95	29.15	5.80	1.66	0.83	0.00	1.33
mesothelioma cell line:NCI-H226	10846-111E9	96.47	59.18	8.51	5.07	0.90	0.90	1.45
mesothelioma cell line:NCI-H2452	10848-111F2	78.58	38.09	4.78	3.93	1.20	0.51	3.07
mesothelioma cell line:NCI-H28	10845-111E8	53.69	29.52	2.29	2.54	1.78	0.25	2.29
mesothelioma cell line:No36	10857-111G2	83.18	31.97	2.28	2.28	0.98	0.00	1.96
mesothelioma cell line:ONE58	10858-111G3	32.51	36.04	4.34	2.98	1.90	0.27	0.54
migratory langerhans cells, donor1	11901-125F2	6.14	19.00	2.30	1.34	0.19	0.00	0.19
migratory langerhans cells, donor2	11902-125F3	4.52	8.18	0.85	0.37	0.37	0.00	0.12
migratory langerhans cells, donor3	11903-125F4	12.92	9.87	2.69	0.90	0.18	0.00	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	52.89	24.49	4.57	2.29	0.65	0.00	8.49
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	49.38	31.58	4.87	2.54	0.64	0.85	1.70
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	35.71	4.38	0.00	0.46	1.84	0.00	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	12.56	6.47	0.38	0.95	0.00	0.00	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	53.96	55.81	4.07	3.51	0.92	0.00	1.29
myeloma cell line:PCM6	10474-106I6	45.66	17.59	2.97	2.37	0.40	0.00	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	28.41	20.29	4.06	0.51	1.01	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	61.59	22.75	2.75	2.55	2.35	0.20	0.98
nasal epithelial cells, donor1, tech_rep1	12226-129F3	39.56	8.69	0.78	1.23	1.11	0.00	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	30.45	8.75	1.18	0.51	1.03	0.07	0.22
nasal epithelial cells, donor2	12227-129F4	29.26	9.38	0.00	1.66	1.10	0.00	0.55
neuroblastoma cell line:CHP-134	10508-107D4	94.32	236.04	18.63	15.64	1.38	0.23	0.69
neuroblastoma cell line:NB-1	10539-107G8	126.66	100.09	11.60	12.16	0.56	0.75	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	93.63	76.13	10.97	5.69	0.00	0.21	2.53
neuroblastoma cell line:NH-12	10555-107I6	64.85	113.86	12.86	8.20	0.75	1.12	1.30
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	89.20	53.14	7.59	5.22	0.00	0.00	4.27
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	88.22	142.70	20.91	13.78	0.48	0.63	2.53
neuroectodermal tumor cell line:TASK1	10774-110F9	86.94	76.68	10.87	10.06	0.40	0.00	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	85.83	36.87	5.72	2.54	0.00	0.00	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	55.63	24.75	2.93	2.40	1.33	0.00	0.80
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	18.94	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	52.43	70.52	25.54	6.26	0.17	0.17	1.18
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	123.28	45.63	7.20	8.81	0.80	4.80	1.60
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	79.51	84.00	8.66	5.77	1.28	0.32	2.56
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	57.81	42.04	3.94	4.20	0.79	0.00	3.68
nucleus accumbens, adult, pool1	10037-101F1	144.26	88.49	13.78	11.34	1.78	1.12	0.75
occipital cortex - adult, donor10196	10172-103C1	92.72	88.60	10.30	8.24	2.06	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	151.63	49.38	5.90	8.32	2.42	4.29	2.68
occipital cortex, newborn, donor10223	10355-105E4	82.62	49.86	11.65	4.37	1.09	0.73	1.82
occipital lobe, adult, donor1	10076-102A4	205.20	65.34	12.60	10.50	0.52	0.26	4.99
occipital lobe, fetal, donor1	10073-102A1	124.87	131.30	11.16	13.73	0.43	0.43	3.86
occipital pole, adult, pool1	10036-101E9	127.25	75.53	12.06	9.62	2.37	1.34	0.47
olfactory region, adult	10195-103E6	124.57	56.17	10.51	8.02	1.53	2.67	1.91
optic nerve, donor1	10277-104E7	70.04	42.02	4.00	0.00	2.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	80.53	33.03	5.24	1.82	0.80	0.23	1.25
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	51.38	22.12	2.75	2.34	1.79	0.00	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	16.09	9.48	0.34	0.68	0.17	0.17	2.03
oral squamous cell carcinoma cell line:SAS	10544-107H4	35.11	24.60	2.77	1.50	0.58	0.00	0.58
osteoclastoma cell line:Hs 706.T	10704-109H2	34.98	24.99	4.12	2.35	2.06	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	21.49	19.62	0.93	3.74	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	80.16	70.40	5.30	7.42	0.42	0.00	0.64
ovary, adult, pool1	10020-101D2	68.66	32.76	3.84	3.84	0.79	0.09	0.61
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	33.00	20.17	4.22	2.20	0.55	0.18	0.73
pancreas, adult, donor1	10049-101G4	94.06	24.46	1.88	0.94	1.88	0.94	4.70
pancreatic carcinoma cell line:NOR-P1	10698-109G5	24.60	16.49	1.68	0.56	0.00	0.00	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	50.25	29.81	3.75	2.21	0.34	0.00	5.11
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	48.18	28.98	3.48	3.15	1.66	0.17	0.66
paracentral gyrus, adult, pool1	10035-101E8	143.60	83.47	13.55	11.17	1.74	2.56	0.46
parietal cortex, adult, donor10258	10373-105G4	39.64	61.66	14.68	5.87	0.73	5.14	2.94
parietal lobe - adult, donor10196	10171-103B9	63.95	53.61	12.23	4.70	2.82	5.64	0.00
parietal lobe, adult, donor10252	10157-103A4	125.13	53.59	5.42	6.27	1.43	4.28	1.43
parietal lobe, adult, pool1	10034-101E7	156.24	72.26	10.57	9.87	1.50	3.08	0.53
parietal lobe, fetal, donor1	10072-101I9	125.11	139.66	16.49	15.52	0.00	0.00	3.88
parietal lobe, newborn, donor10223	10356-105E5	76.64	45.61	8.22	4.11	0.00	1.87	1.50
parotid gland, adult	10199-103F1	34.53	14.80	1.23	0.62	0.62	0.00	2.47
penis, adult	10200-103F2	90.77	16.11	1.61	2.15	1.07	0.00	2.15
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	18.97	16.73	1.12	1.12	0.00	0.19	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	54.64	26.37	2.48	2.33	2.04	0.00	0.58
pineal gland - adult, donor10196	10179-103C8	115.46	131.59	27.09	7.74	4.52	9.68	0.65
pineal gland, adult, donor10252	10160-103A7	301.44	131.47	16.58	14.21	2.96	21.91	0.59
pineal gland, adult, donor10258	10377-105G8	95.94	107.23	30.10	6.27	1.88	15.05	1.88
pituitary gland - adult, donor10196	10180-103C9	88.03	94.10	12.14	7.08	1.01	4.05	3.04
pituitary gland, adult, donor10252	10162-103A9	210.56	104.24	12.51	12.51	2.61	6.25	2.08
pituitary gland, adult, donor10258	10378-105G9	78.31	109.81	11.92	7.66	2.55	5.96	1.70
placenta, adult, pool1	10021-101D3	31.71	27.31	4.30	2.15	0.54	0.00	0.43
plasma cell leukemia cell line:ARH-77	10840-111E3	18.01	14.57	3.44	1.46	0.66	0.13	1.19
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	41.24	41.09	4.51	3.27	0.62	0.00	0.16
pons, adult, pool1	10033-101E6	145.02	75.57	14.63	12.91	2.15	5.25	0.69
postcentral gyrus, adult, pool1	10032-101E5	129.11	79.50	12.90	10.90	2.35	1.83	1.13
promyelocytes/myelocytes PMC, donor1	12132-128D8	127.58	33.46	2.09	2.09	6.27	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	44.06	11.02	5.51	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	46.94	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	61.61	15.29	3.35	2.04	2.77	0.58	0.87
prostate cancer cell line:PC-3	10439-106E7	127.41	18.15	2.18	3.45	0.91	0.00	0.36
prostate, adult, pool1	10022-101D4	53.05	21.58	2.45	2.45	1.09	0.27	1.09
putamen, adult, donor10196	10176-103C5	100.56	95.13	18.89	10.62	2.36	4.49	2.60
putamen, adult, donor10252	10152-102I8	160.78	62.74	7.84	13.73	1.96	1.96	9.80
putamen, adult, donor10258, tech_rep1	10372-105G3	39.34	61.20	17.48	7.65	1.09	2.19	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	67.41	76.83	23.44	4.83	0.97	4.59	0.72
putamen, newborn, donor10223	10365-105F5	31.49	35.23	10.50	0.75	0.00	0.00	3.00
rectal cancer cell line:TT1TKB	10469-106I1	32.58	9.31	0.87	1.75	1.75	0.00	0.00
rectum, fetal, donor1	10067-101I4	223.95	101.54	11.13	8.35	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	84.59	21.41	3.60	1.27	3.18	0.21	1.91
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	22.37	4.14	0.83	0.00	0.41	0.00	0.83
retina, adult, pool1	10030-101E3	140.25	81.51	10.34	7.45	3.08	0.99	1.19
retinoblastoma cell line:Y79	10475-106I7	111.46	68.59	14.03	10.39	1.30	0.00	1.56
rhabdomyosarcoma cell line:KYM-1	10787-110H4	35.53	13.89	2.21	1.35	0.61	0.00	0.37
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	39.37	53.71	4.78	5.34	0.28	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	17.43	9.85	0.00	0.76	0.00	0.00	0.76
salivary acinar cells, donor1	11771-123I7	31.24	13.76	1.78	1.62	0.81	0.65	1.29
salivary acinar cells, donor2	11772-123I8	32.77	13.22	4.27	0.96	1.79	0.69	0.55
salivary acinar cells, donor3	11773-123I9	22.51	7.94	3.31	0.66	0.66	0.00	0.00
salivary gland, adult, pool1	10093-102C3	101.81	13.73	0.57	1.72	1.72	0.57	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	63.15	41.90	5.82	3.04	0.59	0.00	0.84
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	73.12	48.20	5.17	5.17	1.06	0.00	0.82
seminal vesicle, adult	10201-103F3	224.33	38.62	5.29	4.76	3.17	2.65	9.52
serous adenocarcinoma cell line:JHOS-2	10639-108I9	37.90	7.29	0.24	0.73	0.49	0.00	1.94
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	33.72	38.50	4.03	3.52	0.75	0.00	1.51
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	42.15	19.07	4.01	3.01	4.01	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	71.06	29.01	4.30	1.48	0.54	0.00	1.88
signet ring carcinoma cell line:Kato III	10436-106E4	45.87	25.42	3.09	2.87	0.88	0.22	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	254.70	18.58	1.03	2.97	3.74	0.13	1.94
skeletal muscle - soleus muscle, donor1	10282-104F3	69.51	8.51	1.42	3.55	2.84	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	95.23	20.75	2.88	2.28	1.80	1.08	0.84
skeletal muscle, fetal, donor1	10066-101I3	141.71	64.32	12.06	6.03	1.01	0.00	2.01
skin, adult, donor1	10074-102A2	33.93	0.00	0.00	0.00	0.00	0.00	6.79
skin, fetal, donor1	10065-101I2	88.37	68.17	5.05	5.68	2.52	0.00	6.31
small cell cervical cancer cell line:HCSC-1	10800-110I8	89.38	40.36	2.67	4.34	1.00	0.00	1.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	85.11	83.84	10.40	9.14	0.00	0.00	5.67
small cell lung carcinoma cell line:DMS 144	10841-111E4	43.37	23.32	1.16	3.47	5.40	0.00	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	58.35	51.59	8.41	4.62	0.49	0.66	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	64.98	33.46	4.50	5.47	0.97	1.77	1.45
small cell lung carcinoma cell line:WA-hT	10562-108A4	29.20	35.74	4.14	1.96	1.96	0.00	0.22
small intestine, adult, pool1	10024-101D6	353.31	20.31	2.51	3.70	3.11	0.12	2.51
small intestine, fetal, donor1	10064-101I1	258.47	56.51	7.13	8.60	3.19	0.25	6.14
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	51.29	13.34	3.08	0.51	4.10	0.00	3.59
smooth muscle, adult, pool1	10048-101G3	35.93	16.80	1.29	1.03	0.52	0.00	0.26
somatostatinoma cell line:QGP-1	10781-110G7	19.30	6.70	0.54	0.27	2.68	0.27	0.27
spinal cord - adult, donor10196	10181-103D1	133.97	69.97	10.32	12.39	3.90	4.36	1.15
spinal cord, adult, donor10252	10159-103A6	212.91	59.53	9.07	12.22	1.58	4.73	1.58
spinal cord, adult, donor10258	10369-105F9	67.80	87.17	14.53	5.53	1.38	4.15	2.08
spinal cord, fetal, donor1	10056-101H2	175.02	137.82	15.25	16.47	2.44	1.83	6.10
spinal cord, newborn, donor10223	10359-105E8	101.49	38.57	4.59	4.13	0.46	0.00	2.30
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	35.70	22.40	2.09	2.84	1.49	0.30	0.15
spleen, adult, pool1	10025-101D7	40.42	25.77	2.09	2.53	0.55	0.22	0.55
spleen, fetal, pool1	10044-101F8	41.63	31.07	4.77	3.42	0.72	0.95	0.24
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	15.94	3.93	1.04	0.52	0.21	0.52	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	112.60	19.37	1.71	2.28	1.14	0.00	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	36.34	9.78	1.05	1.05	1.75	0.00	2.45
squamous cell carcinoma cell line:T3M-5	10616-108G4	17.59	8.99	0.78	1.56	0.00	0.00	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	62.58	25.10	3.38	2.36	0.79	0.00	0.45
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	51.26	9.74	1.27	0.85	0.42	0.00	1.27
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	19.46	23.27	3.38	2.12	0.85	0.00	0.00
stomach, fetal, donor1	10062-101H8	154.86	40.58	0.00	7.48	1.07	0.00	0.00
submaxillary gland, adult	10202-103F4	50.13	11.96	1.71	2.28	0.57	0.00	4.56
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00	0.00	0.00	54.27	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	168.45	52.76	6.23	8.31	1.25	4.15	2.91
substantia nigra, adult, donor10258	10371-105G2	55.35	85.35	13.45	5.69	0.52	3.10	0.52
substantia nigra, newborn, donor10223	10358-105E7	113.76	36.04	5.65	4.95	2.12	0.00	2.83
synovial sarcoma cell line:HS-SY-II	10441-106E9	49.52	62.59	6.65	6.88	0.69	0.00	0.69
temporal lobe, adult, pool1	10031-101E4	135.29	79.94	12.12	9.75	1.86	1.36	1.19
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	148.15	64.10	7.83	9.97	0.00	0.00	5.70
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	72.52	47.47	4.40	3.52	0.88	0.00	5.27
tenocyte, donor1	11763-123H8	64.93	33.51	2.79	3.14	1.05	0.00	3.84
tenocyte, donor2	11765-123I1	90.42	28.99	2.67	3.43	2.67	0.00	2.67
tenocyte, donor3	11768-123I4	62.27	19.65	1.85	3.34	1.48	0.00	4.82
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	100.96	72.06	9.01	5.10	0.51	0.34	1.36
teratocarcinoma cell line:NCR-G1	10798-110I6	45.47	23.43	4.01	2.93	0.62	0.31	0.31
teratocarcinoma cell line:PA-1	10807-111A6	51.76	30.07	9.30	3.72	0.31	0.00	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	20.31	25.39	3.17	2.54	0.13	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	13.61	5.67	1.89	0.76	0.38	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	13.41	13.09	2.84	2.07	0.11	0.00	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	27.36	15.63	2.28	1.95	0.33	0.00	1.95
testis, adult, pool1	10026-101D8	59.70	55.73	7.09	5.80	1.18	0.11	0.86
testis, adult, pool2	10096-102C6	59.99	65.86	12.18	12.18	1.35	0.00	1.35
thalamus - adult, donor10196	10168-103B6	130.27	79.49	12.14	13.25	2.21	1.10	0.00
thalamus, adult, donor10252	10154-103A1	164.10	47.20	8.60	7.03	1.72	3.13	3.28
thalamus, adult, donor10258, tech_rep1	10370-105G1	70.82	141.64	23.09	7.70	3.08	9.24	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	97.99	63.73	11.20	6.92	1.98	3.79	1.81
thalamus, newborn, donor10223	10366-105F6	59.26	35.09	14.38	2.30	0.00	0.58	2.88
throat, adult	10209-103G2	89.13	17.98	3.00	2.25	2.75	1.00	3.75
throat, fetal, donor1	10061-101H7	120.66	113.66	13.71	14.32	3.35	0.61	1.83
thymic carcinoma cell line:Ty-82	10803-111A2	92.01	65.38	11.73	2.58	0.79	0.40	3.38
thymus, adult, pool1	10027-101D9	24.95	34.40	4.97	1.79	0.40	0.10	0.30
thymus, fetal, pool1	10043-101F7	40.21	35.85	4.88	1.35	0.21	0.52	0.52
thyroid carcinoma cell line:KHM-5M	10776-110G2	29.52	18.22	3.46	1.73	0.93	0.00	1.20
thyroid carcinoma cell line:TCO-1	10783-110G9	55.18	29.89	4.19	1.54	0.70	0.42	0.56
thyroid, adult, pool1	10028-101E1	133.72	43.11	5.23	5.97	4.85	0.75	0.84
thyroid, fetal, donor1	10060-101H6	181.14	54.58	8.44	6.06	3.95	0.53	3.16
tongue epidermis (fungiform papillae), donor1	10288-104F9	61.59	21.56	0.00	0.00	9.24	0.00	0.00
tongue, adult	10203-103F5	66.05	23.03	1.63	1.63	1.40	0.23	2.56
tongue, fetal, donor1	10059-101H5	225.03	68.18	8.28	9.46	4.34	0.00	11.03
tonsil, adult, pool1	10047-101G2	102.18	24.44	2.00	2.10	2.60	1.00	0.60
trachea, adult, pool1	10029-101E2	146.26	20.61	2.04	3.27	3.11	0.41	0.57
trachea, fetal, donor1	10058-101H4	141.18	71.17	8.08	6.92	0.77	0.38	3.08
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	42.16	23.74	3.19	1.42	1.06	0.00	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	39.92	39.21	6.38	2.74	0.91	0.00	0.30
transitional-cell carcinoma cell line:JMSU1	10492-107B6	33.37	19.27	3.45	1.88	0.78	0.00	0.63
tridermal teratoma cell line:HGRT	10694-109G1	26.64	3.81	1.90	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	75.85	30.47	4.23	2.62	1.27	0.08	0.42
umbilical cord, fetal, donor1	10057-101H3	64.68	33.38	8.35	6.26	0.00	0.00	2.09
uterus, adult, pool1	10100-102D1	56.82	24.57	5.12	4.61	0.68	0.00	0.34
uterus, fetal, donor1	10055-101H1	92.66	76.79	7.17	9.73	0.51	0.00	0.00
vagina, adult	10204-103F6	23.91	10.99	0.65	1.29	0.65	0.00	0.00
vein, adult	10191-103E2	46.47	26.74	2.63	3.07	0.66	0.00	1.75
xeroderma pigentosum b cell line:XPL 17	10563-108A5	26.17	13.08	1.34	2.40	0.53	2.67	0.27